Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	iron-responsive element binding	ACO1 IREB2	1.67e-04	3	150	2	GO:0030350
GeneOntologyMolecularFunction	aconitate hydratase activity	ACO1 IREB2	1.67e-04	3	150	2	GO:0003994
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	PLXNA3 CUX2 FN1 MYO7A CNTNAP1 LAMA2 CDH23 ALS2 TECTA TTC3 ADARB1 ZEB2 ANOS1 SLITRK2 LRP2 CDC42 PLXNA1 RAC1 RAC3	2.19e-06	748	150	19	GO:0048667
GeneOntologyBiologicalProcess	positive regulation of lamellipodium assembly	MTOR CDC42 RAC1 RAC2 PLCE1	3.27e-06	32	150	5	GO:0010592
GeneOntologyBiologicalProcess	embryonic morphogenesis	MYH3 COL12A1 FN1 MYO7A HYAL1 HIPK2 CDH23 MED1 TECTA ZEB2 CRYAA SETD2 HOXC11 ALX1 LRP2 PAX3 TMEM231 RAC1	4.50e-06	713	150	18	GO:0048598
GeneOntologyBiologicalProcess	animal organ morphogenesis	KLHL10 SDK2 MYO7A HYAL1 HIPK2 LAMA2 POR CDH23 MED1 TECTA ADARB1 STAT3 CRYAA SETD2 HOXC11 ALX1 CSF3R MTOR LRP2 PAX3 CDC42 NOS3 PLXNA1 RAC1 FBXW11	4.86e-06	1269	150	25	GO:0009887
GeneOntologyBiologicalProcess	positive regulation of lamellipodium organization	MTOR CDC42 RAC1 RAC2 PLCE1	1.02e-05	40	150	5	GO:1902745
GeneOntologyBiologicalProcess	cell morphogenesis	PLXNA3 KLHL10 CUX2 FN1 MYO7A CNTNAP1 LAMA2 CDH23 ALS2 MED1 TECTA TTC3 ADARB1 ZEB2 CRYAA ANOS1 SLITRK2 LRP2 CDC42 CDH10 PLXNA1 RAC1 RAC3	1.75e-05	1194	150	23	GO:0000902
GeneOntologyBiologicalProcess	regulation of lamellipodium assembly	MTOR CDC42 RAC1 RAC2 PLCE1	1.84e-05	45	150	5	GO:0010591
GeneOntologyBiologicalProcess	enucleate erythrocyte development	MED1 RAC1 RAC2	2.06e-05	8	150	3	GO:0048822
GeneOntologyBiologicalProcess	multi-pass transmembrane protein insertion into ER membrane	NOMO1 NOMO2 NOMO3	3.07e-05	9	150	3	GO:0160063
GeneOntologyBiologicalProcess	neuromuscular process	MYH3 MYO7A CNTNAP1 HIPK2 CDH23 PNKD ADARB1 MTOR RAC3	4.09e-05	225	150	9	GO:0050905
GeneOntologyBiologicalProcess	olfactory nerve formation	PLXNA3 PLXNA1	5.25e-05	2	150	2	GO:0021628
GeneOntologyBiologicalProcess	neuron projection development	PLXNA3 CUX2 FN1 HTR7 MYO7A CNTNAP1 LAMA2 CDH23 NCAM2 ALS2 TECTA TTC3 MAPKAPK5 ADARB1 ZEB2 ANOS1 SLITRK2 MTOR LRP2 CDC42 PLXNA1 RAC1 RAC3	5.50e-05	1285	150	23	GO:0031175
GeneOntologyBiologicalProcess	regulation of lamellipodium organization	MTOR CDC42 RAC1 RAC2 PLCE1	5.87e-05	57	150	5	GO:1902743
GeneOntologyBiologicalProcess	axonogenesis	PLXNA3 FN1 CNTNAP1 LAMA2 ALS2 TTC3 ADARB1 ZEB2 ANOS1 SLITRK2 LRP2 PLXNA1 RAC1 RAC3	6.86e-05	566	150	14	GO:0007409
GeneOntologyBiologicalProcess	axon development	PLXNA3 FN1 CNTNAP1 LAMA2 NCAM2 ALS2 TTC3 ADARB1 ZEB2 ANOS1 SLITRK2 LRP2 PLXNA1 RAC1 RAC3	7.11e-05	642	150	15	GO:0061564
GeneOntologyBiologicalProcess	auditory receptor cell morphogenesis	MYO7A CDH23 TECTA RAC1	7.26e-05	31	150	4	GO:0002093
GeneOntologyBiologicalProcess	central nervous system neuron development	PLXNA3 ADARB1 ZEB2 PLXNA1 RAC1 RAC3	8.60e-05	99	150	6	GO:0021954
GeneOntologyBiologicalProcess	stem cell development	FN1 ZEB2 SETD2 ALX1 PAX3 CDC42	9.61e-05	101	150	6	GO:0048864
GeneOntologyBiologicalProcess	olfactory nerve morphogenesis	PLXNA3 PLXNA1	1.57e-04	3	150	2	GO:0021627
GeneOntologyBiologicalProcess	anatomical structure formation involved in morphogenesis	PLXNA3 MYH3 SDK2 COL12A1 FN1 HYAL1 RC3H1 SOX30 CNTNAP1 HIPK2 MED1 ZEB2 STAT3 SETD2 OR10J5 HOXC11 ALX1 CSF3R LRP2 PAX3 CDC42 NOS3 PLXNA1 KNL1	1.77e-04	1483	150	24	GO:0048646
GeneOntologyBiologicalProcess	enucleate erythrocyte differentiation	MED1 RAC1 RAC2	1.97e-04	16	150	3	GO:0043353
GeneOntologyBiologicalProcess	auditory receptor cell development	MYO7A CDH23 TECTA RAC1	2.00e-04	40	150	4	GO:0060117
GeneOntologyBiologicalProcess	embryonic organ development	A2M MYO7A HYAL1 HIPK2 CDH23 MED1 TECTA CRYAA SETD2 HOXC11 ALX1 CDC42 RAC1	2.38e-04	561	150	13	GO:0048568
GeneOntologyBiologicalProcess	neuron projection morphogenesis	PLXNA3 CUX2 FN1 CNTNAP1 LAMA2 ALS2 TTC3 ADARB1 ZEB2 ANOS1 SLITRK2 LRP2 CDC42 PLXNA1 RAC1 RAC3	2.50e-04	802	150	16	GO:0048812
GeneOntologyBiologicalProcess	embryonic organ morphogenesis	MYO7A HYAL1 HIPK2 CDH23 TECTA CRYAA SETD2 HOXC11 ALX1 RAC1	2.55e-04	351	150	10	GO:0048562
GeneOntologyBiologicalProcess	respiratory burst	MPO RAC1 RAC2 RAC3	2.66e-04	43	150	4	GO:0045730
GeneOntologyBiologicalProcess	lamellipodium assembly	MTOR CDC42 RAC1 RAC2 PLCE1	2.78e-04	79	150	5	GO:0030032
GeneOntologyBiologicalProcess	regulation of neuron maturation	MTOR RAC1 RAC3	2.84e-04	18	150	3	GO:0014041
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	PLXNA3 CUX2 FN1 CNTNAP1 LAMA2 ALS2 TTC3 ADARB1 ZEB2 ANOS1 SLITRK2 LRP2 CDC42 PLXNA1 RAC1 RAC3	3.16e-04	819	150	16	GO:0120039
GeneOntologyBiologicalProcess	positive regulation of cellular component biogenesis	CUX2 HYAL1 ADGRL1 DHX33 ARHGEF15 DRG1 SLITRK2 MTOR CDC42 RAC1 MPP7 RAC2 PLCE1	3.38e-04	582	150	13	GO:0044089
GeneOntologyBiologicalProcess	cell projection morphogenesis	PLXNA3 CUX2 FN1 CNTNAP1 LAMA2 ALS2 TTC3 ADARB1 ZEB2 ANOS1 SLITRK2 LRP2 CDC42 PLXNA1 RAC1 RAC3	3.47e-04	826	150	16	GO:0048858
GeneOntologyBiologicalProcess	neuron development	PLXNA3 CUX2 FN1 HTR7 MYO7A CNTNAP1 LAMA2 CDH23 NCAM2 ALS2 TECTA TTC3 MAPKAPK5 ADARB1 ZEB2 ANOS1 SLITRK2 MTOR LRP2 CDC42 PLXNA1 RAC1 RAC3	3.71e-04	1463	150	23	GO:0048666
GeneOntologyBiologicalProcess	stem cell differentiation	A2M FN1 MED1 ZEB2 STAT3 SETD2 ALX1 PAX3 CDC42	4.13e-04	306	150	9	GO:0048863
GeneOntologyBiologicalProcess	homeostasis of number of cells within a tissue	KLHL10 NOS3 RAC1 RAC3	5.15e-04	51	150	4	GO:0048873
GeneOntologyBiologicalProcess	citrate metabolic process	ACO1 IREB2	5.18e-04	5	150	2	GO:0006101
GeneOntologyBiologicalProcess	positive regulation of small molecule metabolic process	CD244 POR STAT3 PPP4R3B MTOR PRKAA1 NOS3	5.21e-04	192	150	7	GO:0062013
GeneOntologyBiologicalProcess	neuromuscular process controlling posture	CNTNAP1 PNKD ADARB1	5.25e-04	22	150	3	GO:0050884
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO1 NOMO2 NOMO3	3.07e-05	9	152	3	GO:0160064
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO1 NOMO2 NOMO3	1.29e-04	14	152	3	GO:0072379
GeneOntologyCellularComponent	NADPH oxidase complex	RAC1 RAC2 RAC3	2.84e-04	18	152	3	GO:0043020
Domain	DUF2012	NOMO1 NOMO2 NOMO3	1.98e-06	4	149	3	PF09430
Domain	DUF2012	NOMO1 NOMO2 NOMO3	1.98e-06	4	149	3	IPR019008
Domain	CarboxyPept_regulatory_dom	NOMO1 NOMO2 CPXM1 NOMO3	2.63e-06	13	149	4	IPR014766
Domain	-	NOMO1 NOMO2 CPXM1 NOMO3	2.63e-06	13	149	4	2.60.40.1120
Domain	CarboxyPept-like_regulatory	NOMO1 NOMO2 CPXM1 NOMO3	8.54e-06	17	149	4	IPR008969
Domain	RHO	CDC42 RAC1 RAC2 RAC3	1.71e-05	20	149	4	PS51420
Domain	Carb-bd-like_fold	NOMO1 NOMO2 NOMO3	2.71e-05	8	149	3	IPR013784
Domain	Aconitase/IRP2	ACO1 IREB2	6.32e-05	2	149	2	IPR006249
Domain	AconitaseA/IPMdHydase_ssu_swvl	ACO1 IREB2	1.89e-04	3	149	2	IPR000573
Domain	Aconitase_C	ACO1 IREB2	1.89e-04	3	149	2	PF00694
Domain	-	ACO1 IREB2	1.89e-04	3	149	2	3.30.499.10
Domain	Acoase/IPM_deHydtase_lsu_aba	ACO1 IREB2	1.89e-04	3	149	2	IPR001030
Domain	-	ACO1 IREB2	1.89e-04	3	149	2	3.40.1060.10
Domain	-	ACO1 IREB2	1.89e-04	3	149	2	3.20.19.10
Domain	Acoase/IPM_deHydtase	ACO1 IREB2	1.89e-04	3	149	2	IPR015937
Domain	Acnase/IPM_dHydase_lsu_aba_1/3	ACO1 IREB2	1.89e-04	3	149	2	IPR015931
Domain	Aconitase/IPMdHydase_lsu_aba_2	ACO1 IREB2	1.89e-04	3	149	2	IPR015932
Domain	ACONITASE_1	ACO1 IREB2	1.89e-04	3	149	2	PS00450
Domain	Aconitase/3IPM_dehydase_swvl	ACO1 IREB2	1.89e-04	3	149	2	IPR015928
Domain	Aconitase	ACO1 IREB2	1.89e-04	3	149	2	PF00330
Domain	Aconitase_4Fe-4S_BS	ACO1 IREB2	1.89e-04	3	149	2	IPR018136
Domain	ACONITASE_2	ACO1 IREB2	1.89e-04	3	149	2	PS01244
Domain	FAD_binding_1	POR NOS3	9.29e-04	6	149	2	PF00667
Domain	-	POR NOS3	9.29e-04	6	149	2	1.20.990.10
Domain	FAD-binding_1	POR NOS3	9.29e-04	6	149	2	IPR003097
Domain	NADPH_Cyt_P450_Rdtase_dom3	POR NOS3	9.29e-04	6	149	2	IPR023173
Domain	FN3	SDK2 COL12A1 FN1 IL20RA NCAM2 ANOS1 CSF3R	1.10e-03	199	149	7	PS50853
Domain	STAT_TF_DNA-bd_sub	STAT2 STAT3	1.29e-03	7	149	2	IPR012345
Domain	STAT	STAT2 STAT3	1.29e-03	7	149	2	IPR001217
Domain	STAT_int	STAT2 STAT3	1.29e-03	7	149	2	SM00964
Domain	STAT_TF_DNA-bd	STAT2 STAT3	1.29e-03	7	149	2	IPR013801
Domain	STAT_bind	STAT2 STAT3	1.29e-03	7	149	2	PF02864
Domain	STAT_int	STAT2 STAT3	1.29e-03	7	149	2	PF02865
Domain	-	STAT2 STAT3	1.29e-03	7	149	2	1.10.532.10
Domain	STAT_alpha	STAT2 STAT3	1.29e-03	7	149	2	PF01017
Domain	-	STAT2 STAT3	1.29e-03	7	149	2	1.20.1050.20
Domain	STAT_TF_prot_interaction	STAT2 STAT3	1.29e-03	7	149	2	IPR013799
Domain	STAT_TF_coiled-coil	STAT2 STAT3	1.29e-03	7	149	2	IPR015988
Domain	-	STAT2 STAT3	1.29e-03	7	149	2	2.60.40.630
Domain	FN3_dom	SDK2 COL12A1 FN1 IL20RA NCAM2 ANOS1 CSF3R	1.46e-03	209	149	7	IPR003961
Domain	Flavodoxin/NO_synth	POR NOS3	1.72e-03	8	149	2	IPR008254
Domain	STAT_TF_alpha	STAT2 STAT3	1.72e-03	8	149	2	IPR013800
Domain	Flavdoxin-like	POR NOS3	1.72e-03	8	149	2	IPR001094
Domain	-	TMEM131 HYDIN	1.72e-03	8	149	2	2.60.40.360
Domain	FLAVODOXIN_LIKE	POR NOS3	1.72e-03	8	149	2	PS50902
Domain	Flavodoxin_1	POR NOS3	1.72e-03	8	149	2	PF00258
Domain	fn3	SDK2 COL12A1 FN1 NCAM2 ANOS1 CSF3R	1.92e-03	162	149	6	PF00041
Domain	Plexin_cytopl	PLXNA3 PLXNA1	2.19e-03	9	149	2	PF08337
Domain	PapD-like	TMEM131 HYDIN	2.19e-03	9	149	2	IPR008962
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXNA3 PLXNA1	2.19e-03	9	149	2	IPR013548
Domain	Plexin	PLXNA3 PLXNA1	2.19e-03	9	149	2	IPR031148
Domain	-	PLXNA3 SDK2 COL12A1 FN1 CD244 IL20RA NCAM2 NOMO1 ANOS1 CSF3R NOMO2 PLXNA1 NOMO3	2.55e-03	663	149	13	2.60.40.10
Domain	A2M	A2M PZP	2.73e-03	10	149	2	PF00207
Domain	A2M_N_2	A2M PZP	2.73e-03	10	149	2	IPR011625
Domain	A2M_comp	A2M PZP	2.73e-03	10	149	2	IPR011626
Domain	A2M_recep	A2M PZP	2.73e-03	10	149	2	PF07677
Domain	A2M_comp	A2M PZP	2.73e-03	10	149	2	PF07678
Domain	-	POR NOS3	2.73e-03	10	149	2	3.40.50.360
Domain	A2M_N	A2M PZP	2.73e-03	10	149	2	PF01835
Domain	A2M_N	A2M PZP	2.73e-03	10	149	2	IPR002890
Domain	A-macroglobulin_rcpt-bd	A2M PZP	2.73e-03	10	149	2	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	A2M PZP	2.73e-03	10	149	2	PS00477
Domain	Flavoprotein-like_dom	POR NOS3	2.73e-03	10	149	2	IPR029039
Domain	Flavoprot_Pyr_Nucl_cyt_Rdtase	POR NOS3	2.73e-03	10	149	2	IPR001709
Domain	A2M_N_2	A2M PZP	2.73e-03	10	149	2	PF07703
Domain	Macroglobln_a2	A2M PZP	2.73e-03	10	149	2	IPR001599
Domain	P-loop_NTPase	MYH3 DNAH3 MYO7A ZGRF1 MCM4 MYO1B DHX33 AK3 DRG1 CDC42 HYDIN RAC1 MPP7 RAC2 RAC3	3.23e-03	848	149	15	IPR027417
Domain	Myosin_head_motor_dom	MYH3 MYO7A MYO1B	3.42e-03	38	149	3	IPR001609
Domain	MYOSIN_MOTOR	MYH3 MYO7A MYO1B	3.42e-03	38	149	3	PS51456
Domain	Myosin_head	MYH3 MYO7A MYO1B	3.42e-03	38	149	3	PF00063
Domain	MYSc	MYH3 MYO7A MYO1B	3.42e-03	38	149	3	SM00242
Domain	FN3	SDK2 COL12A1 FN1 NCAM2 ANOS1 CSF3R	3.72e-03	185	149	6	SM00060
Domain	OxRdtase_FAD/NAD-bd	POR NOS3	3.96e-03	12	149	2	IPR001433
Domain	Carbonic_anhydrase_a-class_CS	CA7 CA8	3.96e-03	12	149	2	IPR018338
Domain	NAD_binding_1	POR NOS3	3.96e-03	12	149	2	PF00175
Domain	Ig-like_fold	PLXNA3 SDK2 COL12A1 FN1 CD244 IL20RA NCAM2 NOMO1 ANOS1 CSF3R NOMO2 PLXNA1 NOMO3	4.33e-03	706	149	13	IPR013783
Domain	TIL_dom	TECTA LRP2	5.40e-03	14	149	2	IPR002919
Domain	PI3/4_kinase_CS	PIK3C3 MTOR	6.20e-03	15	149	2	IPR018936
Domain	Carbonic_anhydrase_a-class	CA7 CA8	6.20e-03	15	149	2	IPR023561
Domain	ALPHA_CA_1	CA7 CA8	6.20e-03	15	149	2	PS00162
Domain	-	DNAH3 MYO7A ZGRF1 MCM4 DHX33 AK3 DRG1 CDC42 HYDIN RAC1 MPP7 RAC2 RAC3	6.81e-03	746	149	13	3.40.50.300
Domain	-	PIK3C3 MTOR	7.05e-03	16	149	2	1.10.1070.11
Domain	Laminin_N	LAMB4 LAMA2	7.05e-03	16	149	2	IPR008211
Domain	PI3Kc	PIK3C3 MTOR	7.05e-03	16	149	2	SM00146
Domain	LamNT	LAMB4 LAMA2	7.05e-03	16	149	2	SM00136
Domain	LAMININ_NTER	LAMB4 LAMA2	7.05e-03	16	149	2	PS51117
Domain	Laminin_N	LAMB4 LAMA2	7.05e-03	16	149	2	PF00055
Domain	Carb_anhydrase	CA7 CA8	7.95e-03	17	149	2	PF00194
Domain	Carb_anhydrase	CA7 CA8	7.95e-03	17	149	2	SM01057
Domain	-	CA7 CA8	7.95e-03	17	149	2	3.10.200.10
Domain	ALPHA_CA_2	CA7 CA8	7.95e-03	17	149	2	PS51144
Domain	Carbonic_anhydrase_a	CA7 CA8	7.95e-03	17	149	2	IPR001148
Pathway	WP_RALA_DOWNSTREAM_REGULATED_GENES	CDC42 RAC1 RAC2 RAC3	1.84e-06	12	113	4	M39408
Pathway	KEGG_MEDICUS_PATHOGEN_HCMV_GH_TO_ITGA_B_RHOA_SIGNALING_PATHWAY	RAC1 RAC2 RAC3	1.71e-05	7	113	3	M47538
Pathway	WP_COMPREHENSIVE_IL17A_SIGNALING	FN1 MCM4 STAT3 PIK3C3 MTOR CDC42 RAC1	2.84e-05	110	113	7	MM16642
Pathway	WP_LEPTIN_SIGNALING	STAT3 MTOR PRKAA1 CDC42 NOS3 RAC1	3.22e-05	76	113	6	M39491
Pathway	WP_EGFEGFR_SIGNALING	SH3GL3 STAT3 GAB2 MTOR CDC42 NOS3 RAC1 PLCE1	4.71e-05	162	113	8	M39334
Pathway	KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY	RAC1 RAC2 RAC3	5.78e-05	10	113	3	M47727
Pathway	KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY	FN1 RAC1 RAC2 RAC3	6.91e-05	28	113	4	M47655
Pathway	WP_INTERFERON_TYPE_I_SIGNALING	STAT2 STAT3 GAB2 MTOR RAC1	7.00e-05	54	113	5	M39435
Pathway	WP_PANCREATIC_ADENOCARCINOMA_PATHWAY	STAT3 MTOR CDC42 RAC1 RAC2 RAC3	7.86e-05	89	113	6	M39732
Pathway	KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY	FN1 RAC1 RAC2 RAC3	9.13e-05	30	113	4	M47718
Pathway	WP_RAS_SIGNALING	HTR7 GAB2 PLA2G4F CDC42 RAC1 RAC2 RAC3 PLCE1	1.15e-04	184	113	8	M39764
Pathway	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION	PLXNA3 PLXNA1 RAC1	1.71e-04	14	113	3	MM15029
Pathway	REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION	PLXNA3 PLXNA1 RAC1	1.71e-04	14	113	3	M7578
Pathway	WP_TARGET_OF_RAPAMYCIN_SIGNALING	MTOR PRKAA1 CDC42 RAC1	1.89e-04	36	113	4	M39635
Pathway	KEGG_PANCREATIC_CANCER	STAT3 CDC42 RAC1 RAC2 RAC3	2.42e-04	70	113	5	M9726
Pathway	KEGG_VIRAL_MYOCARDITIS	MYH3 LAMA2 RAC1 RAC2 RAC3	2.42e-04	70	113	5	M12294
Pathway	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION	PLXNA3 PLXNA1 RAC1	2.60e-04	16	113	3	M16498
Pathway	KEGG_PATHWAYS_IN_CANCER	LAMB4 FN1 LAMA2 STAT3 CSF3R MTOR CDC42 RAC1 RAC2 RAC3	2.81e-04	325	113	10	M12868
Pathway	WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY	PIK3C3 RAC1 RAC2 RAC3	2.86e-04	40	113	4	M39695
Pathway	KEGG_VEGF_SIGNALING_PATHWAY	CDC42 NOS3 RAC1 RAC2 RAC3	3.56e-04	76	113	5	M1749
Pathway	WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME	STAT3 CDC27 RAC1	3.75e-04	18	113	3	M45539
Pathway	PID_ERBB2_ERBB3_PATHWAY	STAT3 MTOR CDC42 RAC1	4.15e-04	44	113	4	M175
Pathway	REACTOME_SIGNALING_BY_MET	FN1 SH3GL3 LAMA2 STAT3 RAC1	4.26e-04	79	113	5	M27643
Pathway	WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY	PIK3C3 RAC1 RAC2 RAC3	4.93e-04	46	113	4	MM15837
Pathway	REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING	IL20RA STAT2 STAT3	5.18e-04	20	113	3	MM15496
Pathway	PID_IL6_7_PATHWAY	A2M STAT3 GAB2 RAC1	5.35e-04	47	113	4	M183
Pathway	KEGG_AXON_GUIDANCE	PLXNA3 CDC42 PLXNA1 RAC1 RAC2 RAC3	5.94e-04	129	113	6	M5539
Pathway	BIOCARTA_SALMONELLA_PATHWAY	CDC42 RAC1	6.27e-04	5	113	2	M16120
Pathway	WP_VEGFAVEGFR2_SIGNALING	FN1 MAPKAPK5 ARHGEF15 STAT3 MTOR PRKAA1 MMP10 CDC42 NOS3 RAC1 FBXW11	6.79e-04	431	113	11	M39729
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES	PIK3C3 RAC1 RAC2	8.98e-04	24	113	3	M27553
Pathway	WP_RANKLRANK_SIGNALING	GAB2 MTOR CDC42 RAC1	9.74e-04	55	113	4	M39667
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES	PIK3C3 RAC1 RAC2	1.01e-03	25	113	3	MM15269
Pathway	REACTOME_METABOLISM_OF_COFACTORS	ACO1 STARD7 NOS3	1.01e-03	25	113	3	M27855
Pathway	REACTOME_METABOLISM_OF_COFACTORS	ACO1 STARD7 NOS3	1.01e-03	25	113	3	MM15574
Pathway	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	GAB2 PLA2G4F CDC42 RAC1 RAC2	1.04e-03	96	113	5	M16121
Pathway	KEGG_FOCAL_ADHESION	LAMB4 FN1 LAMA2 CDC42 RAC1 RAC2 RAC3	1.10e-03	199	113	7	M7253
Pathway	WP_HIPPO_SIGNALING_REGULATION	MTOR PRKAA1 CDC42 CDH10 RAC1	1.14e-03	98	113	5	M39830
Pathway	REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING	IL20RA STAT2 STAT3	1.14e-03	26	113	3	M27750
Pathway	KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY	RAC1 RAC2 RAC3	1.14e-03	26	113	3	M47561
Pathway	KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY	RAC1 RAC2 RAC3	1.14e-03	26	113	3	M47562
Pathway	WP_IL3_SIGNALING_PATHWAY	STAT3 GAB2 CDC42 RAC1 RAC2	1.24e-03	100	113	5	MM15879
Pathway	PID_CXCR4_PATHWAY	STAT2 STAT3 MTOR CDC42 RAC1	1.24e-03	100	113	5	M124
Pathway	REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY	MTOR NOS3 RAC1	1.27e-03	27	113	3	M27422
Pathway	WP_REGULATION_OF_ACTIN_CYTOSKELETON	FN1 PIK3C3 CDC42 RAC1 RAC2 RAC3	1.30e-03	150	113	6	M39520
Pathway	WP_REGULATION_OF_ACTIN_CYTOSKELETON	FN1 PIK3C3 CDC42 RAC1 RAC2 RAC3	1.39e-03	152	113	6	MM15834
Pathway	WP_IL19_SIGNALING	IL20RA STAT3 RAC1	1.42e-03	28	113	3	M48111
Pathway	PID_TRKR_PATHWAY	STAT3 GAB2 CDC42 RAC1	1.44e-03	61	113	4	M187
Pubmed	rac, a novel ras-related family of proteins that are botulinum toxin substrates.	RAC1 RAC2 RAC3	8.51e-08	3	154	3	2674130
Pubmed	Activation of Rac-1, Rac-2, and Cdc42 by hemopoietic growth factors or cross-linking of the B-lymphocyte receptor for antigen.	CDC42 RAC1 RAC2	8.51e-08	3	154	3	12384416
Pubmed	Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size.	MTOR RAC1 RAC2	8.51e-08	3	154	3	21474067
Pubmed	Isoform-specific membrane targeting mechanism of Rac during Fc gamma R-mediated phagocytosis: positive charge-dependent and independent targeting mechanism of Rac to the phagosome.	RAC1 RAC2 RAC3	8.51e-08	3	154	3	16081809
Pubmed	Signaling and cytoskeletal requirements in erythroblast enucleation.	RAC1 RAC2 RAC3	8.51e-08	3	154	3	22461493
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO1 NOMO2 NOMO3	8.51e-08	3	154	3	36011023
Pubmed	Rac signaling in osteoblastic cells is required for normal bone development but is dispensable for hematopoietic development.	RAC1 RAC2 RAC3	8.51e-08	3	154	3	22123845
Pubmed	Rho family GTPases, Rac and Cdc42, control the localization of neonatal dentate granule cells during brain development.	CDC42 RAC1 RAC3	8.51e-08	3	154	3	30387892
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO1 NOMO2 NOMO3	8.51e-08	3	154	3	25576386
Pubmed	Pathophysiological Mechanisms in Neurodevelopmental Disorders Caused by Rac GTPases Dysregulation: What's behind Neuro-RACopathies.	RAC1 RAC2 RAC3	8.51e-08	3	154	3	34943902
Pubmed	The human formin FHOD1 contains a bipartite structure of FH3 and GTPase-binding domains required for activation.	CDC42 RAC1 RAC2 RAC3	1.19e-07	11	154	4	18786395
Pubmed	Plexin signaling via off-track and rho family GTPases.	PLXNA3 PLXNA1 RAC1 RAC2	2.56e-07	13	154	4	11604131
Pubmed	The role of miR-451 in the switching between proliferation and migration in malignant glioma cells: AMPK signaling, mTOR modulation and Rac1 activation required.	MTOR PRKAA1 RAC1	3.39e-07	4	154	3	28440461
Pubmed	Structure of the TPR domain of p67phox in complex with Rac.GTP.	CDC42 RAC1 RAC2	3.39e-07	4	154	3	11090627
Pubmed	Phagocyte NADPH oxidase p67-phox possesses a novel carboxylterminal binding site for the GTPases Rac2 and Cdc42.	CDC42 RAC1 RAC2	3.39e-07	4	154	3	9642115
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO1 NOMO2 NOMO3	3.39e-07	4	154	3	31833031
Pubmed	Mammalian target of rapamycin and Rictor control neutrophil chemotaxis by regulating Rac/Cdc42 activity and the actin cytoskeleton.	MTOR CDC42 RAC1	3.39e-07	4	154	3	24006489
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO1 NOMO2 NOMO3	3.39e-07	4	154	3	9267806
Pubmed	Cadherin-cadherin engagement promotes cell survival via Rac1/Cdc42 and signal transducer and activator of transcription-3.	STAT3 CDC42 RAC1	3.39e-07	4	154	3	19671682
Pubmed	Essential role of Rac1 and Rac3 GTPases in neuronal development.	CDC42 RAC1 RAC2 RAC3	3.57e-07	14	154	4	19126596
Pubmed	Lead exposure, polymorphisms in genes related to oxidative stress, and risk of adult brain tumors.	MPO NOS3 RAC1 RAC2	4.86e-07	15	154	4	19505917
Pubmed	DEF6, a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA.	CDC42 RAC1 RAC2	8.46e-07	5	154	3	15023524
Pubmed	Genetic deletion of Cdc42GAP reveals a role of Cdc42 in erythropoiesis and hematopoietic stem/progenitor cell survival, adhesion, and engraftment.	CDC42 RAC1 RAC2	8.46e-07	5	154	3	16174757
Pubmed	PTEN negatively regulates engulfment of apoptotic cells by modulating activation of Rac GTPase.	RAC1 RAC2 RAC3	8.46e-07	5	154	3	22043008
Pubmed	Genetic polymorphisms in nitric oxide synthase genes modify the relationship between vegetable and fruit intake and risk of non-Hodgkin lymphoma.	MPO NOS3 RAC1 RAC2	1.08e-06	18	154	4	19423521
Pubmed	Rho GTPases and the actin cytoskeleton.	CDC42 RAC1 RAC2	1.69e-06	6	154	3	9438836
Pubmed	Small GTP-binding proteins and the regulation of the actin cytoskeleton.	CDC42 RAC1 RAC2	1.69e-06	6	154	3	7888179
Pubmed	Anosmin-1 modulates fibroblast growth factor receptor 1 signaling in human gonadotropin-releasing hormone olfactory neuroblasts through a heparan sulfate-dependent mechanism.	ANOS1 CDC42 RAC1	1.69e-06	6	154	3	15548653
Pubmed	Regulation of cell protrusions by small GTPases during fusion of the neural folds.	PAX3 CDC42 RAC1	2.94e-06	7	154	3	27114066
Pubmed	Differential properties of D4/LyGDI versus RhoGDI: phosphorylation and rho GTPase selectivity.	CDC42 RAC1 RAC2	2.94e-06	7	154	3	9490022
Pubmed	Polymorphisms in innate immunity genes and risk of childhood leukemia.	MPO CNTNAP1 DHX33 STAT2 STAT3 NOS3 RAC1 RAC2	4.12e-06	206	154	8	20438785
Pubmed	Risk of meningioma and common variation in genes related to innate immunity.	MPO CNTNAP1 DHX33 STAT2 STAT3 NOS3 RAC1 RAC2	4.27e-06	207	154	8	20406964
Pubmed	FBXL5 Inactivation in Mouse Brain Induces Aberrant Proliferation of Neural Stem Progenitor Cells.	ACO1 IREB2 STAT3 MTOR	4.35e-06	25	154	4	28069738
Pubmed	Common variation in genes related to innate immunity and risk of adult glioma.	MPO CNTNAP1 DHX33 STAT2 STAT3 NOS3 RAC1 RAC2	4.42e-06	208	154	8	19423540
Pubmed	Role of the Rho GTPase Rac in the activation of the phagocyte NADPH oxidase: outsourcing a key task.	RAC1 RAC2 RAC3	4.69e-06	8	154	3	24598074
Pubmed	ErbB2 directly activates the exchange factor Dock7 to promote Schwann cell migration.	LRP2 CDC42 RAC1	4.69e-06	8	154	3	18426980
Pubmed	Generation and characterization of Rac3 knockout mice.	RAC1 RAC2 RAC3	4.69e-06	8	154	3	15964829
Pubmed	Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane.	MYO7A CDH23 TECTA	4.69e-06	8	154	3	21165971
Pubmed	Vav GEFs are required for beta2 integrin-dependent functions of neutrophils.	CDC42 RAC1 RAC2	4.69e-06	8	154	3	15249579
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO1 NOMO2 NOMO3	4.69e-06	8	154	3	15257293
Pubmed	CYBA encoding p22(phox), the cytochrome b558 alpha polypeptide: gene structure, expression, role and physiopathology.	RAC1 RAC2 RAC3	4.69e-06	8	154	3	27048830
Pubmed	Redundant functions of Rac GTPases in inner ear morphogenesis.	FN1 MYO7A RAC1 RAC3	5.12e-06	26	154	4	22182523
Pubmed	PlexinA2 and semaphorin signaling during cardiac neural crest development.	PLXNA3 PAX3 PLXNA1	7.01e-06	9	154	3	11688557
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO1 NOMO2 NOMO3	7.01e-06	9	154	3	36261522
Pubmed	Loss-of-Function Mutations in TRAF7 and KLF4 Cooperatively Activate RAS-Like GTPase Signaling and Promote Meningioma Development.	CDC42 RAC1 RAC2	9.99e-06	10	154	3	34215617
Pubmed	Visualization of biochemical networks in living cells.	MTOR CDC42 RAC1	9.99e-06	10	154	3	11438723
Pubmed	Regulation of lymphatic-blood vessel separation by endothelial Rac1.	RAC1 RAC2 RAC3	9.99e-06	10	154	3	19906871
Pubmed	Otogelin, otogelin-like, and stereocilin form links connecting outer hair cell stereocilia to each other and the tectorial membrane.	MYO7A CDH23 TECTA	1.37e-05	11	154	3	31776257
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO1 NOMO2 NOMO3	1.37e-05	11	154	3	32820719
Pubmed	An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance.	ZEB2 NOMO1 NOMO2 NOMO3	1.37e-05	33	154	4	30783098
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	COL12A1 CNTNAP1 MYO1B STARD7 ANKHD1 BABAM2 STAT3 TSFM NDUFS8 DRG1 ERGIC1 CDC123 NOMO2 PIK3C3 CLPTM1 CDC27 CDC42 RAC1	1.89e-05	1297	154	18	33545068
Pubmed	Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells.	CDC42 RAC1	1.95e-05	2	154	2	17356711
Pubmed	A regulated RNA binding protein also possesses aconitase activity.	ACO1 IREB2	1.95e-05	2	154	2	1946430
Pubmed	Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis.	ACO1 IREB2	1.95e-05	2	154	2	14726953
Pubmed	Lysosomal dysfunction and autophagy blockade contribute to autophagy-related cancer suppressing peptide-induced cytotoxic death of cervical cancer cells through the AMPK/mTOR pathway.	MTOR PRKAA1	1.95e-05	2	154	2	32962728
Pubmed	Exenatide inhibits the growth of endometrial cancer Ishikawa xenografts in nude mice.	MTOR PRKAA1	1.95e-05	2	154	2	26648451
Pubmed	Effect of hypoxia on the binding and subcellular distribution of iron regulatory proteins.	ACO1 IREB2	1.95e-05	2	154	2	17200797
Pubmed	Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines.	STAT3 MTOR	1.95e-05	2	154	2	33448097
Pubmed	Down-regulation of placental Cdc42 and Rac1 links mTORC2 inhibition to decreased trophoblast amino acid transport in human intrauterine growth restriction.	CDC42 RAC1	1.95e-05	2	154	2	31825077
Pubmed	Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury.	CDC42 RAC1	1.95e-05	2	154	2	23677246
Pubmed	Lipid raft-associated GTPase signaling controls morphology and CD8+ T cell stimulatory capacity of human dendritic cells.	CDC42 RAC1	1.95e-05	2	154	2	15265891
Pubmed	In vivo role(s) of the iron regulatory proteins (IRP) 1 and 2 in aseptic local inflammation.	ACO1 IREB2	1.95e-05	2	154	2	19533074
Pubmed	Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.	ACO1 IREB2	1.95e-05	2	154	2	15831703
Pubmed	Chlorination and oxidation of human plasma fibronectin by myeloperoxidase-derived oxidants, and its consequences for smooth muscle cell function.	MPO FN1	1.95e-05	2	154	2	30237127
Pubmed	Iron misregulation and neurodegenerative disease in mouse models that lack iron regulatory proteins.	ACO1 IREB2	1.95e-05	2	154	2	25771171
Pubmed	Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL.	STAT3 MTOR	1.95e-05	2	154	2	28082737
Pubmed	Characterization of a second RNA-binding protein in rodents with specificity for iron-responsive elements.	ACO1 IREB2	1.95e-05	2	154	2	8262972
Pubmed	A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients.	CDC42 RAC1	1.95e-05	2	154	2	26071482
Pubmed	Iron regulatory proteins 1 and 2 in human monocytes, macrophages and duodenum: expression and regulation in hereditary hemochromatosis and iron deficiency.	ACO1 IREB2	1.95e-05	2	154	2	16503547
Pubmed	Glycyrrhizic acid inhibits leukemia cell growth and migration via blocking AKT/mTOR/STAT3 signaling.	STAT3 MTOR	1.95e-05	2	154	2	26191214
Pubmed	Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases.	RAC1 RAC2	1.95e-05	2	154	2	14564009
Pubmed	Self-association and ligand-induced conformational changes of iron regulatory proteins 1 and 2.	ACO1 IREB2	1.95e-05	2	154	2	15938636
Pubmed	Rac1 and Rac3 GTPases differently influence the morphological maturation of dendritic spines in hippocampal neurons.	RAC1 RAC3	1.95e-05	2	154	2	31369617
Pubmed	Alsin/Rac1 signaling controls survival and growth of spinal motoneurons.	ALS2 RAC1	1.95e-05	2	154	2	16802292
Pubmed	Knockdown of PLCε inhibits inflammatory cytokine release via STAT3 phosphorylation in human bladder cancer cells.	STAT3 PLCE1	1.95e-05	2	154	2	26156799
Pubmed	Rac regulates PtdInsP₃ signaling and the chemotactic compass through a redox-mediated feedback loop.	RAC1 RAC2	1.95e-05	2	154	2	21976675
Pubmed	Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer.	CDC42 RAC1	1.95e-05	2	154	2	28450422
Pubmed	Inhibition of Rac GTPase signaling and downstream prosurvival Bcl-2 proteins as combination targeted therapy in MLL-AF9 leukemia.	RAC1 RAC2	1.95e-05	2	154	2	21940819
Pubmed	Cloning of the cDNA encoding an RNA regulatory protein--the human iron-responsive element-binding protein.	ACO1 IREB2	1.95e-05	2	154	2	2172968
Pubmed	PDGF-induced human airway smooth muscle cell proliferation requires STAT3 and the small GTPase Rac1.	STAT3 RAC1	1.95e-05	2	154	2	18310224
Pubmed	Human neutrophils utilize a Rac/Cdc42-dependent MAPK pathway to direct intracellular granule mobilization toward ingested microbial pathogens.	CDC42 RAC1	1.95e-05	2	154	2	12511425
Pubmed	Chemoattractant-stimulated Rac activation in wild-type and Rac2-deficient murine neutrophils: preferential activation of Rac2 and Rac2 gene dosage effect on neutrophil functions.	RAC1 RAC2	1.95e-05	2	154	2	12391220
Pubmed	Attenuation of AMPK signaling by ROQUIN promotes T follicular helper cell formation.	RC3H1 PRKAA1	1.95e-05	2	154	2	26496200
Pubmed	Deletion of Rac in Mature Osteoclasts Causes Osteopetrosis, an Age-Dependent Change in Osteoclast Number, and a Reduced Number of Osteoblasts In Vivo.	RAC1 RAC2	1.95e-05	2	154	2	26496249
Pubmed	CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1.	CDC42 RAC1	1.95e-05	2	154	2	8994833
Pubmed	Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor.	ALS2 RAC1	1.95e-05	2	154	2	15033976
Pubmed	Effects of mTOR-STAT3 on the migration and invasion abilities of hepatoma cell and mTOR-STAT3 expression in liver cancer.	STAT3 MTOR	1.95e-05	2	154	2	25063062
Pubmed	Regulation of STAT3 by direct binding to the Rac1 GTPase.	STAT3 RAC1	1.95e-05	2	154	2	11021801
Pubmed	Rac1 and Rac3 GTPases regulate the development of hilar mossy cells by affecting the migration of their precursors to the hilus.	RAC1 RAC3	1.95e-05	2	154	2	21949760
Pubmed	Loss of Either Rac1 or Rac3 GTPase Differentially Affects the Behavior of Mutant Mice and the Development of Functional GABAergic Networks.	RAC1 RAC3	1.95e-05	2	154	2	26582364
Pubmed	The actions of exogenous leucine on mTOR signalling and amino acid transporters in human myotubes.	PIK3C3 MTOR	1.95e-05	2	154	2	21702994
Pubmed	Rac2 is required for the formation of neutrophil extracellular traps.	RAC1 RAC2	1.95e-05	2	154	2	21712395
Pubmed	Cross-talk between Rac1 and Cdc42 GTPases regulates formation of filopodia required for dengue virus type-2 entry into HMEC-1 cells.	CDC42 RAC1	1.95e-05	2	154	2	19710257
Pubmed	The atypical guanine nucleotide exchange factor Dock4 regulates neurite differentiation through modulation of Rac1 GTPase and actin dynamics.	DOCK4 RAC1	1.95e-05	2	154	2	23720743
Pubmed	Involvement of the phosphatidylinositol 3-kinase/rac1 and cdc42 pathways in radial migration of cortical neurons.	CDC42 RAC1	1.95e-05	2	154	2	15557338
Pubmed	Serine-71 phosphorylation of Rac1/Cdc42 diminishes the pathogenic effect of Clostridium difficile toxin A.	CDC42 RAC1	1.95e-05	2	154	2	19709124
Pubmed	Inhibition of Cdc42 and Rac1 activities in pheochromocytoma, the adrenal medulla tumor.	CDC42 RAC1	1.95e-05	2	154	2	27355516
Pubmed	Adiponectin modulates the function of endothelial progenitor cells via AMPK/eNOS signaling pathway.	PRKAA1 NOS3	1.95e-05	2	154	2	28919424
Pubmed	Rac-Dependent Signaling from Keratinocytes Promotes Differentiation of Intradermal White Adipocytes.	RAC1 RAC3	1.95e-05	2	154	2	31351086
Pubmed	Rac1/2 activation promotes FGFR1 driven leukemogenesis in stem cell leukemia/lymphoma syndrome.	RAC1 RAC2	1.95e-05	2	154	2	31221776
Interaction	SUN2 interactions	RC3H1 SH3GL3 CTDNEP1 CDC123 PRKAA1 CDC42 RAC1 RAC2 RAC3 CDHR4 FBXW11	5.86e-07	213	150	11	int:SUN2
Interaction	FLRT2 interactions	ADGRL1 CDC42 RAC1 RAC2 RAC3	2.20e-06	29	150	5	int:FLRT2
Interaction	FBXO2 interactions	PLXNA3 SDK2 COL12A1 FN1 CNTNAP1 NOMO1 CLPTM1 LRP2 TMEM131 TMEM231 PLXNA1 NOMO3 TCTN2 CDHR4	2.50e-06	411	150	14	int:FBXO2
Interaction	MMP2 interactions	A2M COL12A1 FN1 RC3H1 STAT3 MMP10 PZP	3.91e-06	87	150	7	int:MMP2
Interaction	ELMO2 interactions	DOCK4 DRG1 CDC27 RAC1 RAC2 FBXW11	4.52e-06	58	150	6	int:ELMO2
Interaction	CCDC47 interactions	MPO POR CTDNEP1 NOMO1 DRG1 ERGIC1 CDC123 CLPTM1 CDC42 NOMO3 RAC1 RAC2 RAC3 TCTN2	6.72e-06	448	150	14	int:CCDC47
Interaction	ATP1B3 interactions	CNTNAP1 NOMO1 COX5A CDC123 CDC42 RAC1 RAC2 DOP1A RAC3 TCTN2	9.30e-06	231	150	10	int:ATP1B3
Interaction	NCLN interactions	NOMO1 DRG1 CDC123 NOMO2 CDC42 NOMO3 RAC1 RAC2 RAC3	9.53e-06	183	150	9	int:NCLN
Interaction	LAMTOR2 interactions	POR CDC123 MTOR PRKAA1 CDC27 CDC42 RAC2	1.74e-05	109	150	7	int:LAMTOR2
Interaction	DHRS7B interactions	BABAM2 CDC123 PRSS50 CDC42 RAC1 RAC2 TCTN2	1.74e-05	109	150	7	int:DHRS7B
Interaction	STT3B interactions	POR DMXL1 ERGIC1 CDC123 CLPTM1 CDC42 RAC1 RAC2 RAC3 TCTN2	2.26e-05	256	150	10	int:STT3B
Interaction	AMIGO2 interactions	CDC42 RAC1 RAC2 RAC3	2.79e-05	24	150	4	int:AMIGO2
Interaction	CLDN3 interactions	CDC42 RAC1 RAC2 RAC3	2.79e-05	24	150	4	int:CLDN3
Interaction	SCRIB interactions	FN1 P4HA3 ARHGEF15 SETD2 CDC123 PRKAA1 CDC42 RAC1 RAC2 RAC3	3.14e-05	266	150	10	int:SCRIB
Interaction	LLGL1 interactions	DMXL1 ERGIC1 CDC123 CDC42 RAC1 RAC2 RAC3 FBXW11	3.20e-05	164	150	8	int:LLGL1
Interaction	LY86 interactions	PLXNA3 SDK2 DPCD CNTNAP1 NOMO1 TMEM131 PLXNA1 RAC3 TCTN2	3.68e-05	217	150	9	int:LY86
Interaction	PLXNA1 interactions	CDC123 CDC42 PLXNA1 RAC1 RAC2 RAC3 TCTN2	3.80e-05	123	150	7	int:PLXNA1
Interaction	ZDHHC8 interactions	CDC42 RAC1 RAC2 RAC3	3.88e-05	26	150	4	int:ZDHHC8
Interaction	SLITRK4 interactions	CDC42 RAC1 RAC2 RAC3	3.88e-05	26	150	4	int:SLITRK4
Interaction	KIF26B interactions	CDC42 RAC1 MPP7 RAC2 RAC3	4.19e-05	52	150	5	int:KIF26B
Interaction	ANO6 interactions	ERGIC1 CDC123 CDC27 CDC42 RAC1 RAC2 TCTN2	4.66e-05	127	150	7	int:ANO6
Interaction	GPAT4 interactions	ERGIC1 CDC123 CDC42 FEM1A RAC2 RAC3 TCTN2	5.15e-05	129	150	7	int:GPAT4
Interaction	TAFA4 interactions	FN1 CNTNAP1 LRP2 PLXNA1 TCTN2	5.51e-05	55	150	5	int:TAFA4
Interaction	OLR1 interactions	CDC42 RAC1 RAC2 RAC3	6.06e-05	29	150	4	int:OLR1
Interaction	ARMCX3 interactions	POR PNKD NDUFS8 CDC123 PRKAA1 RAC2 RAC3	6.25e-05	133	150	7	int:ARMCX3
Interaction	ARHGAP8 interactions	SH3GL3 CDC42 FEM1A RAC1	6.95e-05	30	150	4	int:ARHGAP8
Interaction	SLITRK5 interactions	CDC42 RAC1 RAC2 RAC3 TCTN2	7.74e-05	59	150	5	int:SLITRK5
Interaction	DCBLD1 interactions	CDC42 RAC1 RAC2 RAC3	7.93e-05	31	150	4	int:DCBLD1
Interaction	SLC16A7 interactions	CDC42 RAC1 RAC2 RAC3	9.01e-05	32	150	4	int:SLC16A7
Interaction	PLCB4 interactions	CDC42 RAC1 RAC2 RAC3	9.01e-05	32	150	4	int:PLCB4
Interaction	LYN interactions	SDK2 CDH23 ADGRL1 MYO1B DHX33 STAT3 GAB2 ERGIC1 CSF3R MICAL3 CDC42 PLXNA1 RAC1 MPP7 RAC2 RAC3	9.54e-05	720	150	16	int:LYN
Interaction	TMCO1 interactions	CUX2 NOMO1 CDC123 CDC42 NOMO3 RAC1 KNL1 TCTN2	9.74e-05	192	150	8	int:TMCO1
Interaction	SLC2A1 interactions	STK17B ADARB1 TSFM ERGIC1 CDC123 CDC42 RAC1 RAC2 RAC3	9.99e-05	247	150	9	int:SLC2A1
Interaction	GLUD2 interactions	SH3GL3 CDC42 RAC2 RAC3	1.15e-04	34	150	4	int:GLUD2
Interaction	SLC6A15 interactions	NOMO1 ERGIC1 CDC123 CDC42 RAC1 RAC2 RAC3	1.17e-04	147	150	7	int:SLC6A15
Interaction	RPN1 interactions	FN1 RC3H1 POR ANKHD1 DMXL1 NOMO1 DRG1 ERGIC1 CDC123 NOMO2 CLPTM1 TMEM131 CDC42 RAC1 RAC2 RAC3 TCTN2	1.21e-04	814	150	17	int:RPN1
Interaction	ARHGEF40 interactions	CDC123 CDC42 RAC1 RAC2 RAC3	1.23e-04	65	150	5	int:ARHGEF40
Interaction	TMEM209 interactions	ERGIC1 CDC123 CDC42 RAC1 RAC2 RAC3 TCTN2	1.28e-04	149	150	7	int:TMEM209
Interaction	ATP11A interactions	CDC42 RAC1 RAC2 RAC3	1.29e-04	35	150	4	int:ATP11A
Interaction	RASA3 interactions	CDC42 RAC1 RAC2 RAC3	1.29e-04	35	150	4	int:RASA3
Interaction	FLVCR1 interactions	ERGIC1 CDC123 CDC42 RAC1 RAC2 RAC3	1.35e-04	105	150	6	int:FLVCR1
Interaction	DIPK1B interactions	RBMS2 CDC123 TCTN2	1.39e-04	14	150	3	int:DIPK1B
Interaction	PCDH17 interactions	CDC42 RAC1 RAC2 RAC3	1.44e-04	36	150	4	int:PCDH17
Interaction	ABL2 interactions	STAT3 CDC42 RAC1 RAC2 SCAI RAC3	1.50e-04	107	150	6	int:ABL2
Interaction	ARHGEF7 interactions	CD244 MTOR CDC42 TRAPPC2L RAC1 RAC2 RAC3	1.51e-04	153	150	7	int:ARHGEF7
Interaction	SDF2L1 interactions	PLXNA3 HYAL1 CNTNAP1 CDC123 CLPTM1 TMEM131 PLXNA1 NOMO3 TCTN2 CDHR4	1.53e-04	322	150	10	int:SDF2L1
Interaction	MUC13 interactions	CDC42 RAC1 RAC2 RAC3	1.61e-04	37	150	4	int:MUC13
Interaction	RRAS2 interactions	STAT3 CDC123 CDC42 RAC1 RAC2 RAC3	1.66e-04	109	150	6	int:RRAS2
Interaction	NDC1 interactions	CTDNEP1 ERGIC1 CDC123 CDC42 RAC1 RAC2 RAC3 TCTN2	1.69e-04	208	150	8	int:NDC1
Interaction	AKAP12 interactions	SH3GL3 CDC123 MTOR CDC42 RAC1 RAC2 RAC3	1.70e-04	156	150	7	int:AKAP12
Interaction	SLC11A2 interactions	CDC42 RAC1 RAC2 RAC3	1.79e-04	38	150	4	int:SLC11A2
Interaction	MTMR1 interactions	CDC42 FEM1A RAC1 RAC2 RAC3 FBXW11	1.83e-04	111	150	6	int:MTMR1
Interaction	SLC19A1 interactions	ERGIC1 CDC42 RAC1 RAC2 RAC3	1.87e-04	71	150	5	int:SLC19A1
Interaction	MELK interactions	RC3H1 CDH23 CDC123 CDC42 RAC1 RAC2	1.92e-04	112	150	6	int:MELK
Interaction	VPS13A interactions	SDK2 CTDNEP1 CDC42 RAC1 RAC2 RAC3	1.92e-04	112	150	6	int:VPS13A
Interaction	PI4K2A interactions	TMEM231 CDC42 NOS3 RAC1 RAC3	2.00e-04	72	150	5	int:PI4K2A
Interaction	DAAM1 interactions	CDC123 CDC42 RAC1 RAC2 RAC3	2.00e-04	72	150	5	int:DAAM1
Interaction	ATP5MF-PTCD1 interactions	RC3H1 TSFM CDC123 CDC42 RAC1	2.00e-04	72	150	5	int:ATP5MF-PTCD1
Interaction	LEMD3 interactions	IREB2 CTDNEP1 ERGIC1 CDC123 CDC42 RAC1 RAC2 RAC3 TCTN2	2.01e-04	271	150	9	int:LEMD3
Interaction	SLC39A14 interactions	ERGIC1 CDC123 CDC42 RAC1 RAC2 RAC3	2.02e-04	113	150	6	int:SLC39A14
Interaction	VEZT interactions	MYO7A CTDNEP1 ERGIC1 CDC42 RAC2 RAC3 TCTN2	2.14e-04	162	150	7	int:VEZT
Interaction	IL6ST interactions	STAT3 CDC42 RAC1 RAC2 RAC3	2.28e-04	74	150	5	int:IL6ST
Interaction	PDF interactions	A2M P4HA3 STAT2 CDC123 RAC1	2.28e-04	74	150	5	int:PDF
Interaction	VAMP7 interactions	CDC123 TMEM231 CDC42 RAC1 RAC2 RAC3	2.33e-04	116	150	6	int:VAMP7
Interaction	AAAS interactions	CTDNEP1 CDC123 CDC42 RAC1 RAC2 RAC3 TCTN2	2.40e-04	165	150	7	int:AAAS
Interaction	STAT1 interactions	DOCK4 POR MYO1B STAT2 STAT3 NOMO1 NOMO2 MTOR CDC42 RAC1	2.49e-04	342	150	10	int:STAT1
Interaction	MPZL1 interactions	STAT3 CDC123 CDC42 RAC1 RAC2 RAC3	2.55e-04	118	150	6	int:MPZL1
Interaction	SLC30A1 interactions	IL20RA ERGIC1 CDC42 RAC1 RAC2 RAC3	2.55e-04	118	150	6	int:SLC30A1
Interaction	GARRE1 interactions	DOCK4 RC3H1 CDC42 RAC1 RAC2 RAC3 FBXW11	2.58e-04	167	150	7	int:GARRE1
Interaction	RELL1 interactions	CDC123 CDC42 RAC1 RAC2 RAC3	2.58e-04	76	150	5	int:RELL1
Interaction	PGRMC2 interactions	POR CTDNEP1 ERGIC1 CDC123 CDC42 RAC1 RAC2 RAC3 TCTN2	2.62e-04	281	150	9	int:PGRMC2
Interaction	POR interactions	POR CTDNEP1 NDUFS8 CDC42 RAC1 RAC2 RAC3 TCTN2	2.63e-04	222	150	8	int:POR
Interaction	EPHA7 interactions	PLXNA3 MYO1B CDC123 TMEM231 PLXNA1 RAC1 MPP7 RAC2 RAC3	2.69e-04	282	150	9	int:EPHA7
Interaction	EXOSC10 interactions	RC3H1 ADARB1 NOMO1 DRG1 ANOS1 CDC123 NOMO2 NOMO3	2.71e-04	223	150	8	int:EXOSC10
Interaction	ARHGDIB interactions	CDC42 RAC1 RAC2 RAC3	2.90e-04	43	150	4	int:ARHGDIB
Interaction	EMC3 interactions	CTDNEP1 CDC42 RAC1 RAC2 RAC3 TCTN2	2.93e-04	121	150	6	int:EMC3
Interaction	THEM6 interactions	CDC123 TMEM231 CDC42 RAC1 RAC2 RAC3	2.93e-04	121	150	6	int:THEM6
Interaction	KRIT1 interactions	PIK3C3 RAC1 RAC2 RAC3	3.18e-04	44	150	4	int:KRIT1
Interaction	IL1RAP interactions	STAT3 CDC123 CCNI RAC1	3.18e-04	44	150	4	int:IL1RAP
Interaction	C2CD2 interactions	CDC42 RAC1 RAC2 RAC3	3.18e-04	44	150	4	int:C2CD2
Interaction	TRAF7 interactions	MAPKAPK5 MMP10 CDC42 RAC1 RAC2 FBXW11	3.20e-04	123	150	6	int:TRAF7
Interaction	CBARP interactions	CDC42 RAC1 RAC2 RAC3 FBXW11	3.28e-04	80	150	5	int:CBARP
Interaction	BRK1 interactions	SDK2 ANKHD1 CDC42 RAC1 RAC2 RAC3	3.34e-04	124	150	6	int:BRK1
Interaction	RFX6 interactions	ZMYND19 TENT5B PRKAA1 CDC42	3.47e-04	45	150	4	int:RFX6
Interaction	DIAPH3 interactions	PNKD CDC123 CDC42 RAC1 RAC2 RAC3	3.49e-04	125	150	6	int:DIAPH3
Interaction	CPB2 interactions	A2M FN1 PZP	3.59e-04	19	150	3	int:CPB2
Interaction	SPCS3 interactions	NOMO1 CDC123 CDC42 RAC1 RAC2 TCTN2	3.64e-04	126	150	6	int:SPCS3
Interaction	LSR interactions	MAPKAPK5 ERGIC1 TMEM231 CDC42 RAC1 RAC2 RAC3	3.67e-04	177	150	7	int:LSR
Interaction	CARMIL1 interactions	CDC123 CDC42 RAC1 RAC2 RAC3	3.68e-04	82	150	5	int:CARMIL1
Interaction	AUP1 interactions	ERGIC1 CDC123 CDC42 RAC1 RAC2 RAC3 TCTN2 FBXW11	3.75e-04	234	150	8	int:AUP1
Interaction	ITGA1 interactions	CDC42 RAC1 RAC2 RAC3	3.77e-04	46	150	4	int:ITGA1
Interaction	ITGA5 interactions	FN1 CDH23 CDC42 RAC1 RAC2 RAC3	3.79e-04	127	150	6	int:ITGA5
Interaction	MED12L interactions	MED6 MED1 SLITRK2 MED12L	4.10e-04	47	150	4	int:MED12L
Interaction	ADIPOR1 interactions	TMEM231 RAC1 RAC3 TCTN2	4.10e-04	47	150	4	int:ADIPOR1
Interaction	PAK3 interactions	POR DRG1 CDC42 RAC1	4.10e-04	47	150	4	int:PAK3
Interaction	SLC38A1 interactions	ERGIC1 CDC123 CDC42 RAC1 RAC2 RAC3	4.12e-04	129	150	6	int:SLC38A1
Interaction	ADGRL1 interactions	ADGRL1 CDC42 RAC1 RAC2 RAC3	4.34e-04	85	150	5	int:ADGRL1
Interaction	CDC42EP1 interactions	ERGIC1 CDC123 CDC42 RAC1 RAC2 RAC3	4.48e-04	131	150	6	int:CDC42EP1
Interaction	SLC38A2 interactions	ERGIC1 COX5A CDC42 RAC1 RAC2 RAC3	4.48e-04	131	150	6	int:SLC38A2
Interaction	ADGRL2 interactions	CDC123 CDC42 RAC1 RAC2 RAC3	4.58e-04	86	150	5	int:ADGRL2
GeneFamily	Rho family GTPases	CDC42 RAC1 RAC2 RAC3	6.49e-06	20	113	4	390
GeneFamily	Fibronectin type III domain containing	SDK2 COL12A1 FN1 NCAM2 ANOS1 CSF3R	5.07e-04	160	113	6	555
GeneFamily	Cyclins\|Mediator complex	MED6 MED1 MED12L	1.13e-03	33	113	3	1061
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	A2M PZP	1.35e-03	9	113	2	1234
GeneFamily	Plexins	PLXNA3 PLXNA1	1.35e-03	9	113	2	683
GeneFamily	Laminin subunits	LAMB4 LAMA2	2.45e-03	12	113	2	626
Coexpression	GU_PDEF_TARGETS_UP	DOCK4 FN1 PIK3C3 RAC2 RAC3 PLCE1	3.35e-06	71	150	6	M3955
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 SPATA6L DCDC1 DENND2B CFAP57 TMEM231 PZP HYDIN CDHR4	2.53e-08	193	154	9	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 DCDC1 CFAP57 TMEM231 PZP HYDIN TCTN2 CDHR4	2.75e-07	185	154	8	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	Control-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	A2M DOCK4 SDK2 FN1 NCAM2 ADARB1 FRMD4B ADRA1A	3.79e-07	193	154	8	5896242f713ae5fd1a4ebb63827f15d7279dced2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	A2M CUX2 COL12A1 LAMA2 MYO1B DENND2B ZEB2 ALX1	4.10e-07	195	154	8	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 SPATA6L DCDC1 CFAP57 TMEM231 HYDIN TCTN2 CDHR4	4.10e-07	195	154	8	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	A2M CUX2 COL12A1 LAMA2 MYO1B DENND2B ZEB2 ALX1	4.10e-07	195	154	8	4f70157d42a16ff0259bc24a62803c4df4285c44
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	A2M DOCK4 SDK2 FN1 LAMA2 CDH23 NCAM2 FRMD4B	4.43e-07	197	154	8	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital\|World / Primary Cells by Cluster	GPR22 TTC3 FRMD4B ZEB2 COX5A CDC42 CCNI RAC3	4.96e-07	200	154	8	6bbe8e1f3e91678f1bfb14945365c1578a59a604
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19\|World / Primary Cells by Cluster	GPR22 TTC3 FRMD4B ZEB2 COX5A CDC42 CCNI RAC3	4.96e-07	200	154	8	c831d9e0a7178e3634da45548f91fa9e8dc6557c
ToppCell	Ciliated_cells-B-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH3 DCDC1 CFAP57 TMEM231 PZP HYDIN CDHR4	1.70e-06	164	154	7	0e9961acbb1d6c0089e6805ba6756736fa4d8bed
ToppCell	Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	DNAH17 PRSS50 LRP2 HYDIN VWA5B1 CDHR4	1.77e-06	105	154	6	76b73bc9236030e0703868fa8f7ecee2affe565b
ToppCell	Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	DNAH17 PRSS50 LRP2 HYDIN VWA5B1 CDHR4	1.77e-06	105	154	6	bfd3395c51a0e868aa92eac4e929de59a3fe8b50
ToppCell	Entopeduncular-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Myoc_(Myoc)--\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	DNAH17 PRSS50 LRP2 HYDIN VWA5B1 CDHR4	1.77e-06	105	154	6	96566c83999aa625c84a4ed18a6df9daa99f9578
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	A2M CUX2 FN1 MCM4 NCAM2 ARSI TCHH	2.08e-06	169	154	7	16c52a0f6d96ecc1832922fce9b39691849f0d73
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DCDC1 CFAP57 TMEM231 PZP HYDIN CDHR4	2.08e-06	169	154	7	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 SPATA6L DCDC1 CFAP57 TMEM231 HYDIN CDHR4	2.43e-06	173	154	7	c3762655caa79ac4879876f470d32578a3c93b01
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	DOCK4 COL12A1 SH3GL3 MYO1B ANOS1 SCAI PLCE1	2.52e-06	174	154	7	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 GPR22 LAMA2 DENND2B ZEB2 ALX1	2.93e-06	178	154	7	78a0c6340001a77f5b2d890b6263f574af2e72da
ToppCell	COVID-19-kidney-REN+Pericyte\|kidney / Disease (COVID-19 only), tissue and cell type	A2M COL12A1 FN1 CNTNAP1 LAMA2 MYO1B ZEB2	3.04e-06	179	154	7	342c1cc4444f51b8dcb30d3adc98285a25669c6e
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DCDC1 CNTNAP1 CFAP57 TMEM231 PZP HYDIN CDHR4	3.16e-06	180	154	7	92fb01b91261b3103454924cde56add337b41844
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M COL12A1 NCAM2 SLITRK2 LRP2 HYDIN PLCE1	3.65e-06	184	154	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M COL12A1 NCAM2 SLITRK2 LRP2 HYDIN PLCE1	3.65e-06	184	154	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M COL12A1 NCAM2 SLITRK2 LRP2 HYDIN PLCE1	3.65e-06	184	154	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 SPATA6L DCDC1 CFAP57 TMEM231 HYDIN CDHR4	3.92e-06	186	154	7	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	A2M DOCK4 FN1 LAMA2 NCAM2 ADARB1 ADRA1A	4.06e-06	187	154	7	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	A2M FN1 LAMA2 CDH23 NCAM2 ADARB1 ADRA1A	4.06e-06	187	154	7	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	Control\|World / Disease state, Lineage and Cell class	DOCK4 HIPK2 POR CDH23 ZEB2 GAB2 CSF3R	4.36e-06	189	154	7	fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 FN1 LAMA2 MYO1B DENND2B ADRA1A	4.67e-06	191	154	7	04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	A2M DOCK4 RBMS2 CDH23 ARHGEF15 NOS3 CA8	4.83e-06	192	154	7	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	A2M DOCK4 SDK2 FN1 NCAM2 ADARB1 FRMD4B	4.83e-06	192	154	7	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M DOCK4 FN1 LAMA2 NCAM2 ADARB1 ADRA1A	5.00e-06	193	154	7	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M DOCK4 SDK2 LAMA2 CDH23 NCAM2 ADARB1	5.00e-06	193	154	7	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 SPATA6L DCDC1 CFAP57 TMEM231 HYDIN CDHR4	5.17e-06	194	154	7	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 SPATA6L DCDC1 CFAP57 TMEM231 HYDIN CDHR4	5.17e-06	194	154	7	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 FN1 LAMA2 DENND2B ZEB2 ADRA1A	5.17e-06	194	154	7	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 LAMA2 MYO1B ZEB2 ALX1 CA8	5.35e-06	195	154	7	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 DCDC1 CFAP57 TMEM231 HYDIN TCTN2 CDHR4	5.35e-06	195	154	7	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	A2M DOCK4 SDK2 FN1 NCAM2 ADARB1 FRMD4B	5.53e-06	196	154	7	6730743cf088c419ccc2d28765769fc09d3ba6a7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 FN1 LAMA2 DENND2B ZEB2 ADRA1A	5.53e-06	196	154	7	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	A2M DOCK4 SDK2 FN1 NCAM2 ADARB1 FRMD4B	5.53e-06	196	154	7	21dab89f3699037138a9c7a0e4dc98739a9fad9c
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M FN1 LAMA2 NCAM2 ADARB1 ARSI ADRA1A	5.53e-06	196	154	7	9737a5f006d37b549f281e1863aca558e1e4dc99
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M DOCK4 FN1 HYAL1 FRMD4B ARHGEF15 NOS3	5.53e-06	196	154	7	8f2031b1a9232c389517fbf3c29f47f9468b0077
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M DOCK4 FN1 HYAL1 FRMD4B ARHGEF15 NOS3	5.53e-06	196	154	7	48b4a9cea97a55190217deaf51bf867608c5a9a7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M DOCK4 FN1 HYAL1 FRMD4B ARHGEF15 NOS3	5.53e-06	196	154	7	473980c827443464d08a0be28c53e3536369b12a
ToppCell	NS-control-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 SPATA6L DCDC1 CFAP57 TMEM231 HYDIN CDHR4	5.53e-06	196	154	7	d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M FN1 LAMA2 NCAM2 ADARB1 ARSI ADRA1A	5.53e-06	196	154	7	cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 DCDC1 DPCD CFAP57 TMEM231 HYDIN CDHR4	5.72e-06	197	154	7	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 SPATA6L DCDC1 CFAP57 TMEM231 HYDIN CDHR4	5.72e-06	197	154	7	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 SPATA6L DCDC1 CFAP57 TMEM231 HYDIN CDHR4	5.72e-06	197	154	7	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M CUX2 LAMA2 ZEB2 STAT2 ALX1 CA8	5.72e-06	197	154	7	b349f8e96d61a4c296af64711e11fc44459a9413
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_PFC-23\|World / Primary Cells by Cluster	SH3GL3 TTC3 FRMD4B ZEB2 COX5A CCNI RAC3	5.72e-06	197	154	7	def63e7e28dd398722e528b7816a34de92552419
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_PFC\|World / Primary Cells by Cluster	SH3GL3 TTC3 FRMD4B ZEB2 COX5A CCNI RAC3	5.72e-06	197	154	7	26fd54acd90292a01ef0d892ba16ccdade987f36
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 SPATA6L DCDC1 CFAP57 TMEM231 HYDIN CDHR4	5.72e-06	197	154	7	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	A2M FN1 LAMA2 NCAM2 ADARB1 ARSI ADRA1A	5.72e-06	197	154	7	13896ec65ccda0b928c91d41112dc01b480036b7
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M CUX2 LAMA2 ZEB2 STAT2 ALX1 CA8	5.72e-06	197	154	7	c2e390653d5dee7e731c1840cfdab41987dede9b
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	A2M FN1 LAMA2 CDH23 NCAM2 ADARB1 ADRA1A	5.91e-06	198	154	7	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	Control_saline-Epithelial_alveolar-AT_1\|Control_saline / Treatment groups by lineage, cell group, cell type	POR MYO1B TENT5B ANOS1 PLXNA1 RAC3 PLCE1	5.91e-06	198	154	7	9b161285df7a4e51618f3517cfc5b8221ba55786
ToppCell	ASK428-Epithelial-Type_1\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	DOCK4 COL12A1 MYO1B STARD7 TENT5B ANOS1 PLCE1	5.91e-06	198	154	7	0047a9ef7684230ac5179efea94461480e90bdaf
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M DOCK4 FN1 LAMA2 NCAM2 ADARB1 ADRA1A	6.31e-06	200	154	7	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 DCDC1 CFAP57 TMEM231 PZP HYDIN CDHR4	6.31e-06	200	154	7	85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c
ToppCell	Biopsy_Control_(H.)-Epithelial-Differentiating_Ciliated\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	DNAH3 DPCD CFAP57 TMEM231 HYDIN CDHR4 PLCE1	6.31e-06	200	154	7	a552a99f5e4fa00dfb7775e5a3e1f62f1530d104
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M FN1 LAMA2 NCAM2 ADARB1 ZEB2 ADRA1A	6.31e-06	200	154	7	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH3 DCDC1 CFAP57 TMEM231 PZP HYDIN CDHR4	6.31e-06	200	154	7	12bc7d95c4166d12487081a76d210b7abe5991b0
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M FN1 LAMA2 NCAM2 ADARB1 ZEB2 ADRA1A	6.31e-06	200	154	7	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	A2M FN1 LAMA2 NCAM2 ADARB1 ZEB2 ADRA1A	6.31e-06	200	154	7	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	Adult-Mesenchymal-chondrocyte\|Adult / Lineage, Cell type, age group and donor	A2M SDK2 FN1 LAMA2 ARSI SLITRK2	1.93e-05	159	154	6	3f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A\|E18.5-samps / Age Group, Lineage, Cell class and subclass	DOCK4 FN1 ADARB1 ZEB2 MICAL3 PAX3	2.30e-05	164	154	6	519ab4fe885dfe4c50846f346a062acc2cb44299
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CD244 HTR7 ZEB2 CSF3R DISP2 RAC2	2.73e-05	169	154	6	c3d410a5e98000ba872141b62e17ef4ed3d1a8eb
ToppCell	Control-Mast_cells\|Control / group, cell type (main and fine annotations)	A2M GALC ALS2 ZEB2 MED12L PZP	2.73e-05	169	154	6	fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 SPATA6L DCDC1 CFAP57 TMEM231 HYDIN	2.73e-05	169	154	6	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	Control-Mast_cells-Mast_cells\|Control / group, cell type (main and fine annotations)	A2M GALC ALS2 ZEB2 MED12L PZP	2.82e-05	170	154	6	c80f6d29096c372da95a8407f402349ff1bb7018
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 FN1 ZGRF1 LAMA2 DISP2 KNL1	2.91e-05	171	154	6	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 FN1 ZGRF1 LAMA2 DISP2 KNL1	2.91e-05	171	154	6	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	P4HA3 ZEB2 TBC1D9 GAB2 DNAH17 TMEM231	3.42e-05	176	154	6	5e46a09a36b9645b1b1fcb0b64bd0898561af3a9
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL12A1 HTR7 FRMD4B ADRA1A SLITRK2 PLCE1	3.65e-05	178	154	6	6ad46b0720298bcb927fd53468bb4ea0c199ad35
ToppCell	normal_Pleural_Fluid-Myeloid_cells-mo-Mac\|normal_Pleural_Fluid / Location, Cell class and cell subclass	A2M DOCK4 CUX2 FN1 ANOS1 MMP10	3.76e-05	179	154	6	cd3c58e044f5a38e815313a1636153d81a592fce
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SDK2 FN1 ADARB1 ZEB2 CPXM1 MICAL3	3.76e-05	179	154	6	b559f5a72cc9e3e35d05cb539b5c2e006e56e652
ToppCell	critical-Lymphoid-NK\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	A2M NCAM2 ARHGEF15 SLITRK2 ALX1 PAX3	3.88e-05	180	154	6	5abf778395392244daaec876f306ed7e4f388686
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH3 DCDC1 CFAP57 TMEM231 HYDIN CDHR4	4.00e-05	181	154	6	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	DNAH3 DCDC1 CFAP57 TMEM231 HYDIN CDHR4	4.13e-05	182	154	6	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 LAMA2 P4HA3 ZEB2 CPXM1	4.13e-05	182	154	6	b7d532feb73167e05475855061b35a209583f44c
ToppCell	NS-critical-d_07-13-Lymphoid-NK\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	A2M NCAM2 ARHGEF15 SLITRK2 ALX1 PAX3	4.13e-05	182	154	6	dd1c59babf7211362452e3e264009d70004d99f6
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M COL12A1 LAMA2 P4HA3 ZEB2 CPXM1	4.13e-05	182	154	6	af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 FN1 LAMA2 DENND2B ZEB2 PLCE1	4.25e-05	183	154	6	667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HTR7 FRMD4B ANOS1 ADRA1A SLITRK2 PLCE1	4.39e-05	184	154	6	2ba98708dfd7f1b2a661578a334684094ff453ad
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL12A1 SH3GL3 MYO1B ANOS1 SCAI PLCE1	4.39e-05	184	154	6	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	IPF-Myeloid-Mast\|World / Disease state, Lineage and Cell class	A2M GALC ALS2 TSEN54 PZP RAC2	4.39e-05	184	154	6	7aefa182acad5a53c730945fec85329d7168606a
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D122\|Adult / Lineage, Cell type, age group and donor	COL12A1 SH3GL3 MYO1B ANOS1 SCAI PLCE1	4.39e-05	184	154	6	561592edc3083fad41b91811151b442207c65dd9
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL12A1 SH3GL3 MYO1B ANOS1 SCAI PLCE1	4.39e-05	184	154	6	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH3 DCDC1 CFAP57 TMEM231 HYDIN CDHR4	4.39e-05	184	154	6	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL12A1 SH3GL3 MYO1B ANOS1 SCAI PLCE1	4.52e-05	185	154	6	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	Ciliated_cells-B-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	DNAH3 DCDC1 CFAP57 TMEM231 HYDIN CDHR4	4.52e-05	185	154	6	4fc7113d3dadc716ec5a8e62b58543cc00ce5b16
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	DNAH3 DCDC1 CFAP57 TMEM231 HYDIN CDHR4	4.52e-05	185	154	6	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	DNAH3 DCDC1 CFAP57 TMEM231 HYDIN CDHR4	4.52e-05	185	154	6	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FN1 HIPK2 CDH23 NCAM2 ADARB1 ZEB2	4.52e-05	185	154	6	1ac6a32cc56d5d819649bdd99518e2ead0eead4c
ToppCell	Ciliated_cells-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH3 DCDC1 CFAP57 TMEM231 HYDIN CDHR4	4.66e-05	186	154	6	f72267d533fd0c5280d9741ceee3dd116300a7e4
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 DCDC1 CFAP57 TMEM231 HYDIN CDHR4	4.66e-05	186	154	6	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	COL12A1 SH3GL3 MYO1B ANOS1 SCAI PLCE1	4.66e-05	186	154	6	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK4 HYAL1 HIPK2 CTIF DENND2B ARHGEF15	4.80e-05	187	154	6	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	Ciliated_cells-B-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DCDC1 CFAP57 TMEM231 PZP HYDIN CDHR4	4.80e-05	187	154	6	2b4262c2e7c7830a976be168cee6eeb738d4feda
Drug	Fe(III	MPO ACO1 POR IREB2 P4HA3 PNKD NDUFS8 SETD2 COX5A MTOR VPS41 MMP10 NOS3 RAC2 PLCE1	2.80e-06	537	150	15	CID000023925
Drug	NSC 23766	MPO CDC42 RAC1 RAC2	5.15e-06	18	150	4	ctd:C487513
Drug	B258	RAC1 RAC2 RAC3	5.52e-06	6	150	3	CID000593690
Drug	pyridine hemochrome	MPO CD244 POR PNKD RAC2	8.11e-06	42	150	5	CID000188327
Drug	blebbistatin	MYH3 FN1 MYO7A MYO1B MTOR CDC42 RAC1	1.20e-05	116	150	7	CID003476986
Drug	4-epidoxorubicin	MYH3 ACO1 HIPK2 POR IREB2 STAT2 STAT3 TBC1D9 COX5A NOMO2 PIK3C3 MTOR CLPTM1 NOS3 PLXNA1 KNL1 CA8	1.81e-05	788	150	17	CID000001690
Drug	Mn(III)TMPyP	ACO1 IREB2 NOS3	2.29e-05	9	150	3	CID005486195
Drug	Simvastatin	MPO A2M COL12A1 FN1 MCM4 STAT3 MTOR PRKAA1 MMP10 CDC42 NOS3 RAC1 RAC2 RAC3	3.16e-05	581	150	14	ctd:D019821
Drug	3 PL	CD244 RAC1 RAC2	3.25e-05	10	150	3	CID000007707
Drug	peroxynitrite	MPO FN1 ACO1 POR IREB2 ALS2 NDUFS8 ADRA1A COX5A MMP10 NOS3	3.85e-05	373	150	11	CID000104806
Drug	AC1L9J09	ACO1 POR IREB2 TSFM PIK3C3	4.02e-05	58	150	5	CID000446034
Drug	nitrotyrosine	MPO ACO1 IREB2 NDUFS8 NOS3 RAC1	4.21e-05	96	150	6	CID000065124
Drug	h 166	MPO FN1	4.31e-05	2	150	2	CID003057962
Drug	p-nitrophenylhydroxylamine	ACO1 IREB2	4.31e-05	2	150	2	CID005486551
Drug	Tetrandrine [518-34-3]; Down 200; 6.4uM; HL60; HT_HG-U133A	DNAH3 FN1 ADGRL1 CTIF BABAM2 STAT2 CDH10 PLXNA1	4.51e-05	194	150	8	2520_DN
Drug	NSC23766	MPO SETD2 CDC42 RAC1 RAC2 RAC3	4.73e-05	98	150	6	CID000409805
Drug	Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; HL60; HG-U133A	MED6 FN1 ORAI2 ADARB1 TSFM NDUFS8 SETD2 CLCN6	4.85e-05	196	150	8	1968_UP
Drug	Colistin sulfate [1264-72-8]; Up 200; 3uM; HL60; HT_HG-U133A	CUX2 GPR22 FN1 CNTNAP1 ADARB1 VPS41 CDC42 DOP1A	4.85e-05	196	150	8	2491_UP
Drug	EDHB	FN1 ACO1 P4HA3 SETD2	4.96e-05	31	150	4	CID000077547
Drug	Amrinone [60719-84-8]; Up 200; 21.4uM; PC3; HT_HG-U133A	LAMB4 HIPK2 LAMA2 IL20RA ADARB1 ADRA1A DNAH17 LRP2	5.02e-05	197	150	8	4488_UP
Drug	Mevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; PC3; HT_HG-U133A	FN1 IREB2 TSFM GAB2 LRP2 TMEM231 RAC3 CA8	5.21e-05	198	150	8	5738_DN
Drug	ferric citrate	ACO1 POR IREB2 PNKD NOMO1	5.55e-05	62	150	5	CID000031083
Drug	AC1MMOKY	MPO GALC NOS3	5.90e-05	12	150	3	CID003289210
Disease	autosomal dominant intellectual developmental disorder 48 (implicated_via_orthology)	RAC1 RAC2 RAC3	1.21e-07	3	147	3	DOID:0080235 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	FN1 LAMA2 CTIF TECTA TTC3 ZEB2 STAT3 CRYAA SETD2 ADRA1A MTOR PRKAA1 MMP10 CDC27 NOS3 CDH10 RAC2 DOP1A	7.09e-06	1074	147	18	C0006142
Disease	Intellectual Disability	CUX2 TSEN54 SETD2 MTOR MED12L LRP2 CDC42 RAC1 RAC3 FBXW11 CA8	1.59e-05	447	147	11	C3714756
Disease	kidney disease (implicated_via_orthology)	CDC42 RAC1 RAC2 RAC3	5.19e-05	41	147	4	DOID:557 (implicated_via_orthology)
Disease	myeloid white cell count	MPO FN1 RC3H1 CDH23 MYO1B CTIF PNKD DENND2B AK3 DRG1 SETD2 OR10J5 CSF3R MED12L PLCE1	7.23e-05	937	147	15	EFO_0007988
Disease	duodenal ulcer (implicated_via_orthology)	ACO1 STAT3	7.37e-05	3	147	2	DOID:1724 (implicated_via_orthology)
Disease	Alzheimer disease type 1	MPO NOS3	1.47e-04	4	147	2	cv:C1863052
Disease	ALZHEIMER DISEASE, FAMILIAL, 1	MPO NOS3	1.47e-04	4	147	2	104300
Disease	vasculitis (is_implicated_in)	MPO NOS3	1.47e-04	4	147	2	DOID:865 (is_implicated_in)
Disease	Ureteral obstruction	FN1 HIPK2 NOS3	2.27e-04	24	147	3	C0041956
Disease	Usher syndrome, type 1A	MYO7A CDH23	2.44e-04	5	147	2	C2931205
Disease	porphyria (implicated_via_orthology)	ACO1 IREB2	2.44e-04	5	147	2	DOID:13268 (implicated_via_orthology)
Disease	USHER SYNDROME, TYPE IB (disorder)	MYO7A CDH23	2.44e-04	5	147	2	C1848638
Disease	USHER SYNDROME, TYPE IA, FORMERLY	MYO7A CDH23	2.44e-04	5	147	2	C1848639
Disease	USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY	MYO7A CDH23	2.44e-04	5	147	2	C1848640
Disease	Usher syndrome type 1	MYO7A CDH23	2.44e-04	5	147	2	cv:C1568247
Disease	Usher Syndrome, Type I	MYO7A CDH23	3.65e-04	6	147	2	C1568247
Disease	myocardial infarction	CUX2 FN1 DENND2B ZEB2 STAT3 COX5A CDC123 NOS3	3.86e-04	350	147	8	EFO_0000612
Disease	Hereditary retinal dystrophy	MYO7A CDH23	5.09e-04	7	147	2	C0154860
Disease	Usher syndrome	MYO7A CDH23	5.09e-04	7	147	2	cv:C0271097
Disease	neutropenia (implicated_via_orthology)	STAT3 CSF3R	5.09e-04	7	147	2	DOID:1227 (implicated_via_orthology)
Disease	Early-onset autosomal dominant Alzheimer disease	MPO NOS3	5.09e-04	7	147	2	cv:CN043596
Disease	Alzheimer's disease (is_implicated_in)	A2M IREB2 STAT3 ADRA1A NOS3	5.34e-04	132	147	5	DOID:10652 (is_implicated_in)
Disease	coffee consumption	LAMB4 CUX2 POR	5.40e-04	32	147	3	EFO_0004330
Disease	Neoplastic Cell Transformation	FN1 POR ZEB2 STAT3 RAC1	6.75e-04	139	147	5	C0007621
Disease	Alzheimer disease	MPO NOS3	6.77e-04	8	147	2	cv:C0002395
Disease	obesity (implicated_via_orthology)	SDK2 DHX33 ADARB1 STAT3 PRKAA1 MED12L	7.52e-04	215	147	6	DOID:9970 (implicated_via_orthology)
Disease	chronic lymphocytic leukemia (is_marker_for)	STAT3 AK3	8.67e-04	9	147	2	DOID:1040 (is_marker_for)
Disease	BMI-adjusted waist circumference, forced expiratory volume	CUX2 MAPKAPK5	8.67e-04	9	147	2	EFO_0004314, EFO_0007789
Disease	vital capacity	NBPF12 FN1 LAMA2 TSEN54 CTIF MED1 ALX1 CDC123 LRP2 DISP2 MICAL3 PLXNA1 VWA5B1 RAC3 PLCE1	1.33e-03	1236	147	15	EFO_0004312
Disease	lymphangioleiomyomatosis (is_marker_for)	STAT3 NOS3	1.57e-03	12	147	2	DOID:3319 (is_marker_for)
Disease	Acute kidney injury	MPO A2M LRP2 NOS3	1.66e-03	101	147	4	C2609414
Disease	Acute Kidney Insufficiency	MPO A2M LRP2 NOS3	1.66e-03	101	147	4	C1565662
Disease	Kidney Failure, Acute	MPO A2M LRP2 NOS3	1.66e-03	101	147	4	C0022660
Disease	blood phosphate measurement	CUX2 DCDC1 OR10J5 TMEM131 KNL1	1.83e-03	174	147	5	EFO_0010972
Disease	iron deficiency anemia (biomarker_via_orthology)	FN1 IREB2	1.85e-03	13	147	2	DOID:11758 (biomarker_via_orthology)
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	MYO7A CDH23 TECTA	2.12e-03	51	147	3	cv:CN043650
Disease	membranous glomerulonephritis (biomarker_via_orthology)	A2M LRP2	2.16e-03	14	147	2	DOID:10976 (biomarker_via_orthology)
Disease	Ciliopathies	MYO7A CDH23 TMEM231 TCTN2	2.27e-03	110	147	4	C4277690
Disease	Neoplasm Invasiveness	FN1 ACO1 IREB2 ZEB2 GAB2	2.34e-03	184	147	5	C0027626
Disease	Meckel-Gruber syndrome	TMEM231 TCTN2	2.48e-03	15	147	2	C0265215
Disease	leukemia	STAT3 SETD2 CSF3R	2.63e-03	55	147	3	C0023418
Disease	Carcinoma, Granular Cell	STAT3 MTOR NOS3 PLCE1	2.75e-03	116	147	4	C0205644
Disease	Adenocarcinoma, Tubular	STAT3 MTOR NOS3 PLCE1	2.75e-03	116	147	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	STAT3 MTOR NOS3 PLCE1	2.75e-03	116	147	4	C0205642
Disease	Carcinoma, Cribriform	STAT3 MTOR NOS3 PLCE1	2.75e-03	116	147	4	C0205643
Disease	Adenocarcinoma, Basal Cell	STAT3 MTOR NOS3 PLCE1	2.75e-03	116	147	4	C0205641
Disease	Adenocarcinoma	STAT3 MTOR NOS3 PLCE1	2.75e-03	116	147	4	C0001418
Disease	isoleucine measurement	LAMA2 DRG1 CFAP57	2.77e-03	56	147	3	EFO_0009793
Disease	basophil count	MPO CUX2 GALC MCM4 PNKD SETD2 CSF3R PLCE1	2.99e-03	483	147	8	EFO_0005090
Disease	FEV/FEC ratio	SOX30 SH3GL3 CDH23 IREB2 TSEN54 BABAM2 DENND2B ZEB2 GAB2 ERGIC1 CDC123 MICAL3 MPP7 CDHR4	3.38e-03	1228	147	14	EFO_0004713
Disease	white matter microstructure measurement	SDK2 DCDC1 HTR7 OR2J3 ANKHD1 FRMD4B LRP2	3.50e-03	390	147	7	EFO_0005674
Disease	Meckel syndrome type 1	TMEM231 TCTN2	3.58e-03	18	147	2	C3714506
Disease	mean arterial pressure	CUX2 DCDC1 HIPK2 MAPKAPK5 TENT5B CLCN6 NOS3 PLCE1	3.64e-03	499	147	8	EFO_0006340
Disease	neutrophil count	MPO CUX2 SPATA6L RC3H1 CDH23 MYO1B PNKD DENND2B TENT5B AK3 DRG1 SETD2 COX5A CSF3R HYDIN	3.85e-03	1382	147	15	EFO_0004833
Disease	hypertension (implicated_via_orthology)	FN1 MTOR LRP2 NOS3	3.91e-03	128	147	4	DOID:10763 (implicated_via_orthology)
Disease	portal hypertension (implicated_via_orthology)	MTOR NOS3	3.99e-03	19	147	2	DOID:10762 (implicated_via_orthology)
Disease	renovascular hypertension (biomarker_via_orthology)	MPO LAMA2	3.99e-03	19	147	2	DOID:1591 (biomarker_via_orthology)
Disease	glomerulonephritis (is_marker_for)	MPO FN1	3.99e-03	19	147	2	DOID:2921 (is_marker_for)
Disease	hydrocephalus (implicated_via_orthology)	DPCD HYDIN	3.99e-03	19	147	2	DOID:10908 (implicated_via_orthology)
Disease	polycystic kidney disease (biomarker_via_orthology)	MTOR NOS3	3.99e-03	19	147	2	DOID:0080322 (biomarker_via_orthology)
Disease	tea consumption measurement	LAMA2 POR MAPKAPK5 FRMD4B	4.02e-03	129	147	4	EFO_0010091
Disease	transient cerebral ischemia (implicated_via_orthology)	ADARB1 STAT3 NOS3	4.04e-03	64	147	3	DOID:224 (implicated_via_orthology)
Disease	maximal midexpiratory flow rate	MED12L MICAL3	4.42e-03	20	147	2	EFO_0004313
Disease	Familial aplasia of the vermis	TMEM231 TCTN2	4.42e-03	20	147	2	cv:C0431399
Disease	haptoglobin measurement	CMTR2 HYDIN	4.86e-03	21	147	2	EFO_0004640

Protein segments in the cluster

Peptide	Gene	Start	Entry
TRANYLASPPLVIAY	ACO1	546	P21399
TYDISVLPRTDSYPQ	ALX1	206	Q15699
LQTTSGPYLLIYPQL	C2orf16	1136	Q68DN1
TSPYVYQLTTRPVTD	CNTNAP1	1126	P78357
LTPPITQYYNRTIQK	CTIF	581	O43310
IPSYPDTQAVNEYLR	ALS2	336	Q96Q42
QAVHTPLQSPREYLY	ARSI	236	Q5FYB1
EIYYTSRPPALVARN	ADGRL1	1421	O94910
IGVSYPLRYPTIVTQ	ADRA1A	126	P35348
QSSLPLNSVYVYRPL	CCNI	251	Q14094
YQDLPNPVFRYLQSV	CMTR2	691	Q8IYT2
TYYTLPNATVAPETR	CPXM1	466	Q96SM3
YAYIQRIPVPNLVDS	DOP1A	1906	Q5JWR5
PLQDEPLYQTYRAAV	ARHGEF15	346	O94989
AYQLEPYPSQQTIEL	CUX2	1186	O14529
RNTYLPEVSYQFPKL	DENND2B	711	P78524
NRPIFSQPLYNISLY	CDH23	456	Q9H251
TKPRVIDLSQYSPTY	DMXL1	1466	Q9Y485
LSPQTTDYQVPSLKY	DISP2	421	A7MBM2
IPQEPQRLIYSYSIV	CDHR4	576	A6H8M9
YVLLAYLTAQPAPTS	A2M	1211	P01023
VPSYVPESRERYQQI	RC3H1	701	Q5TC82
SYVLLAYLTAQPAPT	PZP	1216	P20742
STLPRSQYDYILPQV	NOMO3	1116	P69849
PYLSSPVSSYQRVTQ	RBMS2	281	Q15434
QEDYDRLRPLSYPQT	RAC2	61	P15153
QEDYDRLRPLSYPQT	RAC3	61	P60763
QEDYDRLRPLSYPQT	RAC1	61	P63000
VRANYLASPPLVVAY	IREB2	621	P48200
LDVRPPYAEYLQVVN	P4HA3	416	Q7Z4N8
VQLETQYQYPRPLLI	ORAI2	81	Q96SN7
THLTYRIVNYTPDLP	MMP10	111	P09238
HYVLTVPNLRPSTLY	ANOS1	616	P23352
NLYRQLISYPQEVIP	MCM4	221	P33991
TVNPIYKYILNDLPR	DCDC1	41	M0R2J8
STLPRSQYDYILPQV	NOMO2	1116	Q5JPE7
PGQSPQLLIYTLSYR	IGKV2D-40	66	P01614
SQYSIDPVTRYPNIN	MICAL3	461	Q7RTP6
ANPEVSILNYPSTLY	HIPK2	606	Q9H2X6
QSNIYRVPPNYSPIS	MED12L	1786	Q86YW9
TPYYVAPQVLEAQRR	MAPKAPK5	186	Q8IW41
QLPDYTSPVVLPYSR	DRG1	301	Q9Y295
LTYYLDITNPPRTNV	POR	371	P16435
QYDYLDPRQITPSLE	MTO1	406	Q9Y2Z2
YLLAQTSPPESNLVY	CFAP57	121	Q96MR6
PYVYAFLQTKVPQRS	AK3	206	Q9UIJ7
SVPLYNTLLPYTFLE	FSIP2	4456	Q5CZC0
QPYLLDPSITLGQYV	TSFM	286	P43897
LLVLNSTSFLYYPDP	PLXNA1	1136	Q9UIW2
IYTYTQDPTVTRLEP	PLXNA3	1016	P51805
LPTYRSYNDSVDPRI	MPO	476	P05164
SPITVKYTERRQPLY	ERGIC1	236	Q969X5
PNSFYRSLYPKIIQD	FBXW11	201	Q9UKB1
VPTYEEVTPYRRQTN	MPP7	351	Q5T2T1
STLPRSQYDYILPQV	NOMO1	1116	Q15155
LAVLLQTSPEAPYIY	DPP3	46	Q9NY33
QTSPEAPYIYALLSR	DPP3	51	Q9NY33
LSPSQYINEENLPVY	KNL1	1731	Q8NG31
ISRTPYNILSSPDYV	LAMA2	2501	P24043
PINYTTRRIGPVTYS	LAMA2	2891	P24043
TETNPQVYYQASLRP	LRP2	631	P98164
QEDYDRLRPLSYPQT	CDC42	61	P60953
TYRVQYIQDIILPTP	PPP4R3B	266	Q5MIZ7
NPYPIYTSVNVRTNL	PLA2G4F	491	Q68DD2
YQRISNIEDLPPLYT	ADARB1	601	P78563
SSTPINTRIEPYYSI	GPR75	471	O95800
LQYSYTPQLQDLDPL	IL20RA	446	Q9UHF4
TLSYLFREPATINYP	NDUFS8	71	O00217
QLPLLQPRYYSVSSA	NOS3	931	P29474
TLPTYQLSETSYQPT	PAX3	301	P23760
VYNPLPSPSRQYTEI	FRMD4B	986	Q9Y2L6
EPNLTYVYPHTRIQS	CLCN6	606	P51797
IPITFYPRESINYQE	HYDIN	4376	Q4G0P3
YAYTRTVPITPDNVE	KLHL10	96	Q6JEL2
YTNPDSRYILLPVVL	DOCK4	821	Q8N1I0
EATQVYPKLYLSPRI	BABAM2	211	Q9NXR7
NSEVTVQPSPYLSYR	CDC123	291	O75794
PVQQYRIIYSPTVGD	COL12A1	2051	Q99715
YEYLGNTPRLVITPL	DNAH17	1811	Q9UFH2
YITTRLRNPHYLPEV	DNAH3	3171	Q8TD57
TYLLPVVISDNDYPI	CDH10	561	Q9Y6N8
YPLRNLQPASEYTVS	FN1	1051	P02751
TIYAITPTYSRPVQK	B3GAT2	81	Q9NPZ5
IRNLPYPKDVYSVSV	DPCD	106	Q9BVM2
YDPSLLDVRLSPNYV	CA8	61	P35219
PPQLVLAYDYSREVN	FEM1A	341	Q9BSK4
PLYASLPYAQQLRVF	DHX33	326	Q9H6R0
PFQLYEIIVTPLYQD	CSF3R	496	Q99062
LPQAPSRQISYPYSA	HOXC11	51	O43248
SRQISYPYSAQVPPV	HOXC11	56	O43248
NPYSPYIQDLVTLTN	LAMB4	211	A4D0S4
PGQSPQLLIYTLSYR	IGKV2-40	66	A0A087WW87
YPSNLVYSTEPLISQ	KRTAP23-1	31	A1A580
VYSPSLQPLELSYEA	CA7	41	P43166
LPVLPYVQIFYDTTN	HYAL1	281	Q12794
LLPFLSSTISPYYRQ	CRYAA	36	P02489
YQPLSYPLSFQVSLT	GPR22	31	Q99680
EIYPYVIQELRPTLN	COX5A	121	P20674
ATSRLLVNYPEPYRS	GALC	66	P54803
PVRYYTIQTRELPSG	SDK2	1431	Q58EX2
SYLQNYTNTPPVIDV	CDC27	296	P30260
APTSQEPAYTLYSLI	CD244	306	Q9BZW8
ETQPTYAPLYELITQ	MED1	331	Q15648
RQSPAQVIPLADYYI	MED6	86	O75586
YSVVTPLLNPVIYSL	OR11G2	316	Q8NGC1
YTVLSPTLNPLIYTL	OR13A1	296	Q8NGR1
TYTIITPLLNPVVYS	OR10J5	276	Q8NHC4
YTVVTPSLNPLIYTL	OR2J3	281	O76001
RYHPQALIYPLTVAS	MTOR	1966	P42345
QPTLSTSAPQEYLYL	GAB2	181	Q9UQC2
LYRELNSSPQPYLVP	TAF4	641	O00268
STSEVNYIIERPSYP	SPATA6L	366	Q8N4H0
ENYPLYIRSTPTENE	TRAPPC2L	11	Q9UL33
VLPIPVLSDNYSYLI	PNKD	121	Q8N490
YSVQPYTKEVLQSLP	STAT2	626	P52630
LSKTTEYLQPNPAYR	SH3GL3	51	Q99963
YVVRRFQPSSVLSPY	TSEN54	166	Q7Z6J9
YSTLSIPPERLASYQ	NBPF12	836	Q5TAG4
YSILSNPNPSDYVLL	PLCE1	2176	Q9P212
LNIIVSYPPTKQLTY	PIK3C3	296	Q8NEB9
FTTVSLLQPPQYRIY	SLITRK2	51	Q9H156
YLAPEILNYDPITTA	STK17B	201	O94768
LLLITTNPYDYPFIS	MYH3	301	P11055
YTSIAPLLNPFIYTL	OR6C6	276	A6NF89
PYRSPTYSVVIPSLQ	SOX30	441	O94993
ATVNYYVTPVQPLLA	TENT5B	401	Q96A09
IFYTPQYLNPSVISL	PRKAA1	241	Q13131
YLGITRPLTYPVRQN	HTR7	181	P34969
YLLDYPNNVLSVPTT	ANKHD1	686	Q8IWZ3
YYPINESLASLPLRV	CLPTM1	291	O96005
IQYQTVRYDILPLSP	CTDNEP1	36	O95476
APNLTIISPVYFYIN	TECTA	1536	O75443
LLAPATYRPVTYQSL	TBX10	316	O75333
PLYLIYPSVENVRTS	TDP1	436	Q9NUW8
PPNLDLLKYNRSYTV	ZNF684	141	Q5T5D7
PIEEQFPVLNVTRYY	ZMYND19	136	Q96E35
QEYILALADVPSSPY	NCAM2	486	O15394
LRIIPDSNYYFPTAE	SPIN4	176	Q56A73
DATNILVSPLVYLYP	STAT3	661	P40763
VYVQFIPLALYSNPS	TMEM131	861	Q92545
SSARVAPYRILYQTP	TBC1D9	56	Q6ZT07
INVLPGLPQYTSIYT	TTC3	1336	P53804
TSIYTPLASLSPEYQ	TTC3	1346	P53804
IFRETRNYPESYPQL	SCAI	556	Q8N9R8
QISLYAEYDRPNLLP	VPS41	616	P49754
TPPIVQSYAQPSLQY	SETD2	2316	Q9BYW2
NAIIRYPVEVISYQP	TMEM231	246	Q9H6L2
YFNPATLPLTQYLLT	ZGRF1	1551	Q86YA3
YLLTYSDNPQTVFPR	STARD7	286	Q9NQZ5
YLQRSDTAIIYPEAP	ZEB2	166	O60315
YSLSTNSPPLIQYVQ	TRIM64	386	A6NGJ6
KSEAPPIYLQVSSYQ	PRSS50	336	Q9UI38
YSLSTNSPPLIQYVQ	TRIM64B	386	A6NI03
ASVPVRSSPLYEYIQ	TCHH	1921	Q07283
LPHPLTRFQINYTEY	TCTN2	626	Q96GX1
VSKSRYLPTVVEYPN	VWA5B1	906	Q5TIE3
YLPTVVEYPNSAALR	VWA5B1	911	Q5TIE3
VVISVNPYRSLPIYS	MYO1B	51	O43795
NPYQLLSIYSPEHIR	MYO7A	106	Q13402
PSRNYTPYTRVLELT	MYZAP	446	P0CAP1